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Post-transcriptional processing of mRNA subsequently determines its longevity, 
transport, and gene expression. Alternative polyadenylation (APA), one form of post-
transcriptional processing, is the use of a variant polyadenylation signal and polyA-site 
for transcript cleavage and addition of adenine residues. The occurrence of this 
phenomenon in the 3’-untranslated region (3’UTR) can lead to transcript isoforms 
differing in 3’UTR length and as a result, alter the downstream cis-regulatory elements 
in use. Transcript modification at the 3’-end in alternative polyadenylation has been 
shown to foster a number of diseases in altering what would otherwise be normal protein 
expression and is furthermore emerging as a driver of spermatogenesis.  
To date, the global mechanisms that control the post-transcriptional processing in 
male germ cells remain unknown. PolyA-seq is a strand-specific, quantitative method 
for the high-throughput sequencing of 3’-ends of transcripts post-transcriptionally 
modified in polyadenylation. It has the ability to accurately and globally map polyA-
sites. To study the molecular regulation of sperm production, an in-depth bioinformatics 
analysis was performed on available PolyA-seq data to identify male germ cell 
transcripts that uniquely use alternative polyadenylation, a novel method was developed 
to isolate and purify male germ cells from testicular tissue, and libraries were prepared 
for PolyA-seq from isolated male germ cells.  
Findings show no significant global difference in polyadenylation signal use 
between testicular and liver tissues when the same polyadenylation site is compared for 
human PolyA-seq data. Further annotation suggests a conservation in polyadenylation 
signal and polyA-site use across tissue types in the same species. Transcripts in the liver  
  
 
 were more likely to use the canonical polyadenylation signal in comparison to those in 
the testis, lending further evidence of increased variant polyadenylation signal use in 
male germ cells attributed to alternative polyadenylation. Moreover, manual 
identification of known alternatively polyadenylated transcripts in testis from mice 
suggests that PolyA-seq is a reliable method for transcriptome characterization. 
Isolation and purification of male germ cells was successful using DRAQ5 nuclear 
stain. Using the verified isolated male germ cells, PolyA-seq libraries were generated. 
Comparison of different polyadenylation sites for the same transcripts between testis 
and liver PolyA-Seq still needs to be conducted. Also, increasing yields of polyA+ 
RNA for PolyA-Seq library prep will facilitate successful sequencing of 3’-ends. 
Further investigation of male germ cell-specific transcripts associated with alternative 
polyadenylation will lead to an improved understanding of molecular regulation 
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CHAPTER 1: LITERATURE REVIEW 
 
Male Infertility 
Infertility, clinically defined as the inability to bear a child after a year of 
unprotected intercourse, affects 15% of all couples looking to conceive (Agarwal et al., 
2008; Rockett et al., 2004). Over 40% of cases are afflicted by male factor infertility 
(Jamsai, 2011; Patel, 2011). Male factor infertility can be acquired and/or congenital. 
Acquired male infertility may result from hormonal imbalances, lifestyle, and 
environmental factors that affect male sperm count and quality (Saner-Amigh & 
Halvorson, 2011). Underlying genetic aberrations, such as chromosomal abnormalities 
and microdeletions in the Y chromosome, account for 10-15% of cases (Ferlin et al., 
2007). Genetic mutations impacting the development and function of the endocrine and 
urogenital system can lead to defective erection, ejaculation, gametogenesis, 
fertilization, or embryonic development, and results in idiopathic male infertility, which 
impacts 25% of all infertile men (Roy et al., 2007; Matzuk & Lamb, 2008). 
Male infertility is routinely evaluated by semen analysis, where an ejaculate is 
used to assess abnormal sperm morphology, concentration, and motility. Alone these 
methods do not serve as an accurate indicator for fertility potential as many other sperm 
functional components are not assayed. For a significant number of men with normal 
semen analysis results, full-term pregnancy is still out of reach and the underlying cause 
of infertility cannot be diagnosed (Garrido et al., 2009; Matzuk & Lamb, 2008; Lee & 
Foo, 2014). The complex multifactorial etiologies involved in male factor infertility and 
the limitations of current routine analyses emphasize the need for a more accurate and 
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universal test. A distinctive aspect of gene expression in male germ cells during 
spermatogenesis holds promise as a marker for male infertility. 
Spermatogenesis   
 Spermatogenesis is the highly-ordered and precisely timed process of male germ 
cell development and maturation. The process, which takes place in the testes, occurs 
uniformly throughout the lifespan of a male. During spermatogenesis, primordial germ 
cells develop into diploid stem cell spermatogonia in the testicular seminiferous 
epithelium. After numerous cycles of mitosis and cell renewal, spermatogonia develop 
into spermatocytes. Spermatocytes complete two meiotic divisions, undergoing genetic 
recombination and reduction of chromosomes, to produce haploid round spermatids. 
During the post meiotic phase, round spermatids experience transcriptional arrest as 
histones are replaced by transition proteins, followed by protamines. The process of 
unique chromatin remodeling enables for the compaction of chromatins in the sperm 
head. Spherical round spermatids then enter spermiogenesis, a four-step process where 
the sperm head and tail terminally differentiate to form haploid spermatozoa with highly 
condensed DNA (Figure 1). Spermatozoa empty into the lumen of the seminiferous 
tubules where they go through final maturation and are stored in the cauda epididymis 
until ejaculation (Eddy, 1998; Gilbert, 2000; Braun, 2001; Senger, 2003; White-Cooper 
& Davidson, 2011). Development of the male germ cell from spermatogonia to fully 
differentiated spermatozoa occurs in close association with testicular somatic cells 
including the supporting Sertoli cells, testosterone-producing Leydig cells, and 
structural peritubular myoid cells.   
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 Unlike somatic cells, male germ cell function and development is regulated by 
unique gene expression and endocrine signaling (Eddy, 1998). A number of genes 
encoding for proteins specific to the structural and functional development of 
spermatogenic cells, including those involved in meiosis and the specialized 
differentiation process of spermiogenesis (e.g. transition proteins 1 and 2, protamines 1 
and 2, and synaptonemal complex protein 1 genes), are upregulated in testicular tissue 
and downregulated in somatic tissue—earning the name, “Chauvinist genes” (Eddy, 
1998). Unique to male germ cell development is also the increased frequency of 
alternatively polyadenylated transcripts through the use of variant polyadenylation sites, 
which is the focus of this research. 
Polyadenylation and alternative polyadenylation  
 In eukaryotes, the nascent RNA is transcribed from DNA containing coding 
exons and intervening introns. Introns are excised via RNA splicing and the transcript 
is post-transcriptionally modified with the addition of a 5’ cap, transcript cleavage, and 
addition of a string of adenine residues (poly-A tail) to generate the mature messenger 
RNA (mRNA). Structurally, mRNA contains a coding region, an area composed of 
exons that is translated into protein, and untranslated regions (UTRs), non-coding 
regions that flank both the 5’- and 3’-ends (Figure 2). The post-transcriptional addition 
of a poly-A tail to a transcript is known as polyadenylation and is required for the 
synthesis, processing, nuclear export, and stability of eukaryotic mRNA.  
Use of variant cleavage sites within a 3’UTR generates transcript isoforms in a 
process called alternative polyadenylation. To generate an alternatively polyadenylated 
transcript, selection of different poly(A) signal (PAS) within the 3’UTR by recognition 
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proteins directs the site of mRNA cleavage and addition of the poly-A tail. The process 
begins with recognition and binding of the PAS, typically the canonical hexamer 
sequence AAUAAA, by the protein complex Cleavage and Polyadenylation Specificity 
Factor (CPSF). After CPSF recognition and binding in the 3’UTR, cleavage stimulation 
factor (CstF) binds downstream in a GU rich region and CPSF-73, a subunit nuclease 
of CPSF, cleaves at the polyA-site about 20 nucleotides downstream of the PAS. The 
polyadenylate polymerase (PAP) enzyme adds about 250-300 adenine nucleotides to 
the 3’end of the transcript to form the poly-A tail (Di Giammartino et al., 2011; Mandel 
et al., 2006; Figure 3). Use of a PAS and polyA-site located proximal to the transcript 
coding region can generate transcript isoforms with short 3’UTRs, compared to use of 
a PAS and polyA-site distal to the coding region (Figure 4). 
The 3’UTR is a non-coding region that contains many sequence elements, such 
as RNA-binding protein and microRNA (miRNA) binding sites, which are targeted by 
post-transcriptional regulatory elements. As such, cleavage in the 3’UTR from 
alternative polyadenylation can result in transcripts with the same coding region and 
thus production of the same protein, but result in varied 3’UTR lengths. The resulting 
variation of regulatory element composition on the 3’UTR can alter downstream 
transcript regulation, stability, and localization (Di Giammartino et al., 2011; Gupta et 
al., 2014). Alternative polyadenylation can occur in a tissue or cell-specific manner and 
produce transcripts expressing different 3’UTR lengths in different tissues (Di 
Giammartino et al., 2011). This research focuses on male germ cell transcripts with a 




The impact of alternative polyadenylation on transcript use   
 It is estimated that over 50% of genes in humans and 32% of target genes in 
mice undergo alternative polyadenylation (Shi, 2012; Tian et al., 2005). The differential 
regulation of mRNA transcripts can alter gene expression necessary for specific 
biological processes. For example, short 3’UTR mRNA isoforms have been observed 
to produce as much as 40-fold more protein by excluding the regulatory impact of 
miRNAs and other RNA-binding elements (Lianoglou et al., 2013). miRNAs are non-
coding RNA that complementarily antisense bind to target mRNA, usually in the 
3’UTR, for translational repression in blocking mRNA target site or induction of mRNA 
degradation through cleavage. Their binding often changes the subsequent timing of 
translation and transcript expression levels (Bartel, 2004; Mayr & Bartel, 2009; Liaw et 
al., 2013). Loss of miRNA regulation is estimated to account for 25-67% of increased 
protein expression related to truncated 3’UTRs, leaving the remainder of difference in 
protein expression between long and short mRNAs attributed to repression from other 
regulatory elements lost in alternative polyadenylation (Mayr & Bartel, 2009).  
Alterations in 3’UTR length facilitate the exclusion or inclusion of sequence 
motifs that can affect the lifespan of an mRNA transcript. Short mRNA isoforms were 
on average 2.6 times more stable than their long mRNA isoforms in the different tissues 
and genes (Mayr & Bartel, 2009) while isoforms differing in a single nucleotide in the 
3’-end dramatically affected the decay rate (Gupta et al., 2014). Different polyA-site 
selection in alternative polyadenylation can furthermore affect transcript localization 
patterns. Sequence motifs present in the 3’UTR attract RNA-binding proteins that signal 
molecular motor transport of transcripts. In neurons, learning-related plasticity and 
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memory storage require specific subcellular transport of transcripts to axons or dendrites 
(Mitra et al., 2015; Martin et al., 1997). Brain-derived neurotrophic factor (BDNF) 
transcripts are expressed as long isoforms in the cell soma and dendrite. Mice expressing 
only short isoforms of BDNF experienced long-lasting impairment in dendritic 
potentiation not seen in the cell soma (Martin et al., 1997). 
Alternative polyadenylation is emerging as a characteristic trait of highly 
proliferative cells. In cancer cells and neuronal stem cells, this observation primarily 
manifests as short 3’UTR leading to loss of miRNA binding sites and an increase in 
protein production. In this case, truncated 3’UTRs result in a degree of miRNA 
exclusion that would otherwise keep cell growth in check, resulting in enhanced stability 
and protein production (Di Giammartino et al., 2011; Mayr & Bartel, 2009). Direct 
sequencing has revealed that cancer tissues preferentially express isoforms with the 
shortest 3’UTR (Lin et al., 2012). In a subset of mantle cell lymphoma, short 3’UTR 
isoforms in CCNDI lead to a 1.6-fold increase in Cyclin D1 expression, correlating with 
increased proliferation of lymphoma cell (Mayr & Bartel, 2009). Furthermore, short 
3’UTR isoforms of proto-oncogene insulin-like growth factor 2 mRNA binding protein 
1 (IGF2BP1/IMP-1) have been shown to exhibit increased oncogenic transformation in 
comparison to its full-length counterpart (Mayr & Bartel, 2009).  
Short 3’UTRs were also more commonly found in highly expressed genes in a 
study analyzing murine C2C12 myoblasts in their differentiated and proliferative states. 
The same phenomenon of high prevalence of short 3’UTRs associated with upregulation 
is present in the analyses of breast cancer cell lines compared with normal breast tissue, 
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and tumor necrosis factor alpha (TNFα)-treated lymphoblasts compared with untreated 
cells (Ji et al., 2011).  
IMP-1 is an RNA-binding protein heavily expressed in numerous types of 
human cancers, including lung, colon, and breast cancer. It is believed to play a role in 
stabilizing target mRNAs such as β-catenin, c-myc, and β-TrCP1 (Mayr & Bartel, 
2009). Expression vectors with full-length IMP-1 isoforms, designed with mutations to 
prevent cleavage from alternative polyadenylation, produced results relative to an empty 
vector. In contrast, expression of the short isoforms significantly promoted cellular 
transformation due to loss of miRNAs. The short isoform was able to transform human 
breast epithelia and fibroblast cell lines, demonstrating that loss of repressive regulatory 
3’UTR elements through different polyA-site use can enhance protein expression and 
translationally promote tumorigenesis and the pathogenesis of cancer (Mayr & Bartel, 
2009). 
Alternative polyadenylation in male germ cells 
As with highly proliferative cells, alternative polyadenylation is emerging as a 
driver for male germ cell gene expression. Previous studies have reported variation in 
the use of specific polyadenylation signals between pre-meiotic spermatogonia and 
post-meiotic round spermatids, with round spermatids using the canonical 
polyadenylation signal AA(U/T)AAA less frequently (Lui et al., 2007). Moreover, 
round spermatids had a shorter median length for the 3’UTR (Lui et al., 2007). High 
usage of non-canonical polyadenylation signal and poly-A site in spermatogenic cells 
result in an overexpression of the short 3’UTR isoform compared to somatic cells. This 
suggests that alternative polyadenylation functions to regulate male germ cell transcripts 
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(Liu et al., 2007; McMahon et al., 2006; Sartini et al., 2008). Using ESTs, differences 
in 3’-processing site usage and median 3’UTR lengths were found for male germ cells: 
spermatogonia (220 nt), spermatocytes (260 nt), and round spermatids (150 nt), while 
somatic Sertoli cells had a higher median length (400 nt) (Liu et al., 2006).  
Studies of individual transcripts show that several testicular transcripts exist in 
a short 3’UTR isoform when compared to somatic transcript expression (Table 1). 
Several transcripts are expressed as testis-specific isoforms with a short 3’UTR in 
addition to longer 3’UTR isoforms that are also expressed in testis and somatic tissues 
(i.e. Bzw1, Cpsf6, Nudt21, RNF4, and RanGAP1). Two 3’UTR isoforms can also been 
expressed exclusively in male germ cells. For example, the transcript Deleted in 
AZoospermia Associated Protein 1 (DAZAP1) exists as two different 3’UTR isoforms 
in male germ cells. DAZAP1 is a heterogeneous ribonucleoprotein particle highly 
expressed in late stage spermatocytes and post-meiotic spermatids that regulates 
translation during spermatogenesis. In the absence of Dazap1, mice experience arrest in 
spermatogenesis and growth retardation. Dazap1 3’UTR transcript isoforms are 
generated through APA--2.4-kb (Dazap1-L) and 1.8-kb (Dazap1-S). Translation of the 
two Dazap1 transcripts are differentially regulated, with Dazap1-S exhibiting 
translational repression associated with inactive messenger ribonucleoprotein particles 
and a longer poly(A)-tail in comparison to Dazap-L (Yang & Yen, 2013).  
The 3' UTR contributes to gene regulation in male germ cells. In transgenic 
mice, the 3'UTR of normal transition protein 2 (Tnp2) was replaced with the 3'UTR 
from the human growth hormone gene (hGH). Disruption of the normal 3'UTR resulted 
in premature translation of Tnp2 and infertile males with defective spermatid 
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morphology and failure of spermatozoa formation (Tseden et al., 2007). Similarly, 
generated transgenic mice with Tnp2 3'UTR replaced with the 3'UTR of hGH resulted 
in abnormal sperm head morphology, reduced sperm motility, and male infertility 
(Tseden et al., 2007).  
Evidence of further germ cell-specific characteristics can be observed in the 
polyadenylation process. Mammalian germ cells have been found to express a cell-
specific variant of Cstf2, a subunit of the CstF complex, known as Cstf2t (Dass et al., 
2007). The variant is primarily expressed in meiotic pachytene spermatocytes and post-
meiotic spermatids. A germ cell-specific variant of cytoplasmic poly(A) polymerase has 
been similarly been identified (Liu et al., 2007). These germ cell-specific factors suggest 
that polyadenylation and 3’-processing may differ in male germ cells, and contribute to 
specialized germ cell function.  
While it is evident that the 3’UTR impacts post-transcriptional modification, 
gene expression, and its truncation in alternative polyadenylation appears to be 
characteristic of male germ cells, the importance in the use of a different polyA-site and 
PAS within the 3’UTR during spermatogenesis is not known. To elucidate the 
functional purpose of alternative polyadenylation in male germ cell development, a 
global assessment of all transcripts is necessary. 
Global mapping of alternative polyadenylation (APA) transcripts 
Several hundred APA transcripts from a variety of tissue types have been 
identified and studied by Northern blotting. These RNA gels typically require lengthy 
incubations, and radioactive RNA probes for hybridization but can identify different 
mRNA isoforms for only one gene at a time. Analysis of EST databases was a first 
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attempt to identify more APA genes in humans and mice. With EST libraries, 
polyadenylation sites were computationally derived, but high cost and limited data did 
not make this a viable approach for global analysis (Shi, 2012; Tian et al., 2005; Elkon 
et al., 2013). Microarrays have been instrumental in APA gene profiling with the ability 
to measure quantitative gene expression. The ratio of RNA probe fluorescent intensities 
are used to detect widespread APA changes. However, microarrays, can only capture 
verified transcripts and limit data output only to what is already known about the 
transcriptome. Thus, they cannot directly map, accurately quantify, or detect novel 
polyadenylation signals (Shi, 2012).  
High-throughput sequencing plays a critical role in determining the overall 
usage and function of APA in specific tissues. RNA 3’UTR and PAS-use profiles on 
various tissues have been characterized in mammals, yeast, fruit fly (Drosophila), 
nematode (Caenorhabdits elegans), and thale cress (Arabidopsis) using high-
throughput sequencing. This approach has allowed for more insight into tissue-specific 
use of APA, discoveries of new APA regulators, and changes in APA linked to human 
diseases (Shi, 2012). While several different sequencing approaches have been 
developed—poly (A) capture, sequencing alternative polyA-sites (SAPAS), direct RNA 
sequencing (DRS), 3’READS (Hogue et al., 2014), MAPS (Zhou et al., 2014), RNA-
Seq direct sequencing (Ozsolak et al., 2010), PA-Seq (Ni et al., 2013), PAS-Seq 
(Shepard et al., 2011), and multiplex RNA-seq (Fox-Walsh et al., 2011)—the focus of 
this research is using the Poly(A)-Sequencing (Sun et al., 2012, Derti et al., 2012).  
PolyA-seq is a strand-specific, quantitative method for sequencing 3’ 
polyadenylated ends (Derti et al., 2012). PolyA-seq is a modification of the deep 
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sequencing-based method, Poly(A) Site Sequencing (PAS-Seq) that can quantitate 
polyadenylation in RNA. PolyA-seq uses a modified RNA-Seq cDNA library protocol 
to immediately capture transcript sequence upstream of the polyA-site, preserve strand 
specificity, represent transcriptional abundance, and quantitate the amount of use in any 
given polyA-site. The method uses random priming in second-strand synthesis to 
rapidly generate a library. Internal priming events, which may occur at internal 
transcript A-rich sequences and account for false discovery rates, are eliminated through 
calibrated and rigorous filtering. Aligned 5' ends with unaligned adenine stretches on 
the 3'-end are considered as authentic polyA-sites. Annotated 3'UTRs are clustered and 
known and novel polyA-sites mapped (Derti et al., 2012). The process involves the 
conversion of RNA into a cDNA library (typically fragments of 30-400 base pairs), 
followed by the attachment of sequence adaptors to each fragment (either to one or both 
ends), the binding of fragments to flow cells, solid-phase bridge amplification via PCR, 
and the repeated base-by-base sequencing of fragments using fluorescence emission. 
The resulting reads are then aligned to a reference genome or assembled de novo, to 
produce a genome-scale map. Identical reads are clustered and quantified to give an 
accurate output on expression levels, relative abundance, and transcriptional structure 
(Wang et al., 2009).  
Presently, PolyA-seq has been used to globally map polyA-sites in twenty-four 
tissues types in dog, human, mouse, and rat, and has discovered almost 300,000 novel 
sites (Derti et al., 2012). While this study sequenced the polyA-sites in testis, the 
presence of somatic cells obscures the APA events for the developing male germ cells. 
A genome-wide profile on male germ cell polyadenylation signal (PAS) and polyA-site 
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use has yet to be established and presents a knowledge gap that can potentially lead to 
greater understanding of APA in spermatogenesis. Characterization of male germ cell 
functional PAS and polyA-sites involved in APA using PolyA-seq has the potential to 
increase understanding in the molecular regulation of sperm production and identify 
precise causes of male infertility. 
The aims of this project: 1) identify transcripts in testicular tissue with short 
isoforms from existing literature, 2) identify transcripts that use a different PAS in testis 
compared to the liver at the same polyA-site location as determined by its genomic 
coordinate, 3) develop a novel germ cell isolation method, and 4) generate PolyA-seq 
libraries from isolated male germ cells. Identified candidate transcripts will then be used 
for further functional studies of the role of the 3’UTR. This study hypothesizes that 
transcripts will be identified in male germs cells that have shorter 3’UTR transcripts in 




CHAPTER 2: BIOINFORMATICS ANALYSIS OF DIFFERENTIAL 




Alternative polyadenylation (APA) occurring in the 3’UTR generates transcripts 
with a different length 3’ untranslated region (3’UTR). APA is characteristic of highly 
proliferative cells such as cancer cells, neurons, and is emerging as a defining trait of 
spermatogenic cells (Liu et al., 2007; McMahon et al., 2006; Sartini et al., 2008). Male 
germ cells have a prevalence for transcripts with a short 3’UTR compared to somatic 
testicular cells and among different male germ cell types as found by analyzing EST 
libraries (Liu et al., 2007). The truncated 3’UTR in male germ cell transcript suggest 
that specific regulation of mRNA translation or metabolism is unique in developing 
germ cells. Characterization of male germ cell functional PAS, the signal for cleavage 
of a 3’UTR therefore determining its length, has the potential to increase understanding 
in the molecular regulation of sperm production and identify precise causes of male 
infertility. However, the role of APA in male germ cells is not completely understood. 
PolyA-seq is a novel high-throughput, strand-specific quantitative method for 
sequencing 3’ polyadenylated ends (Derti et al., 2012). PolyA-seq is a modification of 
the high-throughput RNA Sequencing (RNA-Seq) method, which can sequence total or 
fractionated RNA; and the PAS-seq method, which can quantitate polyadenylation in 
RNA transcripts. It is not limited to characterized transcripts and is powerful for the 
detection of mRNA isoform expression and quantification. PolyA-seq has been used to 
analyze polyA-site use in several tissues and has found that over 69% of known human 
genes have multiple polyA-sites in the 3’UTR (Derti et al., 2012). In addition, polyA-
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site usage appears to be similar across same types of tissues in different species rather 
than within the same species, indicating that there may be conserved tissue-specific 
regulation (Derti et al., 2012).  
PolyA-seq data for mouse testis and liver was analyzed to compare reported PAS 
use with previously published transcripts to determine if PolyA-seq is a reliable 
predictor of tissue-specific PAS selection. Bioinformatics analysis of available human 
testis and liver PolyA-seq data was conducted to determine if there is a difference in 
PAS use in testis in comparison to liver somatic tissue at the same polyA-site (Figure 
5). To test this hypothesis, PAS and number of reads for testis and liver from human 
and mouse from previously published PolyA-seq data (Derti et al., 2012) were compared 
to discern differential expression. Transcripts with use of the same polyA-site between 
testis and liver were annotated and characterized using gene ontology. Identification of 
unique transcripts involved in spermatogenesis has the potential to elucidate targets that 
may provide further insights in the diagnosis and treatment of male infertility. 
METHODS 
Obtaining PolyA-seq raw data 
Since experimental design uses tissue samples from mouse model organisms 
with the ultimate end goal of scientific discovery with beneficial implications in human 
male reproductive biology, sequencing data was collected from species Homo sapiens, 
sequenced with biological replicates, and Mus musculus. PolyA-seq text files were 
downloaded from ArrayExpress Archive of Functional Genomics Data 
(http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-30198/samples/) for testis 
and liver tissue for both respective organisms (Derti et al., 2012). PolyA-Seq text files 
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contained information for polyA-site location, PAS, number of reads, and polyA score, 
a log-likelihood score reflecting the probability that the observed site is genuine and not 
an internal priming event.  
Manual searching for known testis APA transcripts 
Known testis-specific transcripts involved in alternative polyadenylation were 
manually identified in the data set by searching for genomic coordinates for the 
transcript of interest (mouse NCBI37/mm9 July 2007) with the predicted PAS in the 
PolyA-Seq for testis and liver. Transcripts were further validated by comparing 
polyadenylation signal(s) in the data set with reported polyadenylation signal(s) in 
published literature.  
Data parsing and gene annotation of testis and liver PolyA-seq 
A program was written in Perl to open the sequencing text files for testis and 
liver, match transcripts according to their polyA-site location with a margin of 100bp, 
and create an output file containing associated information for tissue-specific 
comparison of PAS usage. For the subsequent processing steps, codes were written in 
visual basic for applications (VBA) to develop macros within Excel to compare testis 
and liver PolyA-seq for PAS usage at the genomic coordinate, which in this case 
represents the location of the polyA-site used. Current sequencing and annotation data 
from the National Center of Biotechnology Information (NCBI) was used as reference 
files. Chromosome assembly data from Genome Reference Consortium Human Build 
38 patch release 2 (ftp://ftp.ncbi.nih.gov/genomes/Homo_sapiens) and Genome 
Reference Consortium Mouse Build 38 patch release 3 
(ftp://ftp.ncbi.nih.gov/genomes/M_musculus/), were extracted for genomic coordinate 
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ranges, gene short names, full gene names, and accession numbers for all contained 
mRNA and miscellaneous RNA identifiers. This collection is an amalgamation of 
computational sequencing and annotation, manual curation, and predictive annotation. 
The Genome Reference Consortium Mouse Build 38 patch release 3, part of the mouse 
RefSeq project assembly on the C57BL/6J strain, at the time of its release date in 
February 2015, represents 71% of total protein-encoded transcripts annotated and 38% 
of which with known RefSeq accessions (McGarvey et al., 2015). The data then became 
the processed reference files used to match the output file for each respective organism. 
Comparison of testis and liver polyA-signal use at the same polyA-site 
For each chromosome, transcript polyA-site genomic coordinates were matched 
with coding region genomic coordinates as reported by NCBI with a margin of 100bp. 
For each successfully referenced match, output data printed information on reported 
gene name, gene short name, and accession number if available to yield a list of 
annotated transcripts. From the full list of transcripts, a subset, termed “honed”, was 
created with transcripts where reads in testis were greater than those in liver and both 
tissues utilized a different PAS at the same polyA-site. This function was performed by 
first determining if the PAS in testis matched with the PAS in liver. Transcripts with the 
same PAS were then deleted, leaving only transcripts with varying polyadenylation 
signals for the same chromosome and polyA-site within 100bp. Transcripts were then 
sorted in ascending order by difference between testis and liver number of reads and 
anything equal to or less than 0 were deleted, leaving only transcripts where testis reads 
are greater than liver reads by at least one.  
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Complete polyadenylation signals and respective transcript frequencies were 
recorded for both groups—comprehensive and honed transcripts—and both tissue 
types. Student’s unpaired T-test was performed on human data, where replicates were 
available, to determine statistical significance in PAS usage. Due to limitations of the 
reference annotation and sequencing data, annotations failed to exceed a certain 
genomic coordinate threshold. For specific known transcripts of interest, manual 
annotations were completed. Gene ontology analysis was conducted using the Protein 
ANalysis THrough Evolutionary Relationships (PANTHER) Classification System 
(pantherdb.org) to classify biological processes.   
Individual tissue annotation and analysis using comprehensive PolyA-seq data 
 Raw PolyA-seq mouse data for testicular and liver tissue were individually 
annotated to identify potential transcript isoforms resulting from APA. PolyA-site 
genomic coordinates from were matched with reference files with a 100bp margin to 
produce an output annotation file containing chromosome number, polyA-site, polyA-
score, PAS, number of reads, strand sense, accession number, short gene name, and long 
gene name. From this, transcript isoforms were identified from annotations using a 
different polyA-site and an identifiable PAS.  
RESULTS 
PolyA-seq data for mouse testis and liver was manually searched to compare 
reported PAS use with previously published transcripts to determine if PolyA-seq is a 
reliable predictor of tissue-specific PAS selection. Manual mining of the testis and liver 
PolyA-seq for known APA testis transcripts identified 10 of 14 known transcripts. PAS 
for five known APA transcripts (NUDT21, ARF, eIF-2a, ERCC6 and Klf4) were not 
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identified in either the testis or liver PolyA-seq data. The PAS identifying the 3’UTR 
end for 6 of these transcripts, identified by Northern blots and, in some cases, 3’RACE, 
were confirmed in the PolyA-seq data. For three other transcripts: CPSF6, DAZAP1, 
DlnB/POLK and SP1, additional PAS were identified.  
In human samples, from the 19,906 and 10,179 individual transcripts identified 
in the testis and liver PolyA-seq, 0.718-0.844% of the comprehensive transcripts were 
annotated (Table 2). In order to identify ubiquitous transcripts upregulated in testicular 
tissue as a potential byproduct of APA, a data subset—so called “honed”--was created. 
From the comprehensive transcripts, transcripts were parsed where the number of reads 
in testis were greater than those in liver by at least one and PAS usage differed at the 
same polyA-site--irrespective of available annotation. The analysis aimed to identify 
novel transcripts where isoforms may exist due to 3’UTR post-transcriptional 
modification. From the comprehensive transcripts in human, 5.435% and 5.363% were 
extracted to form the honed subset (Table 2). Where canonical PAS was used in liver, 
testis transcripts had an overwhelming preference for PAS: ATTAAA. This preference 
was similarly observed vice versa where canonical PAS expression in testis showed a 
dramatic expression of PAS: ATTAAA in liver transcripts. In general, PAS usage at the 
same polyA-site was not different for both tissue types from human PolyA-seq analysis 
(Table 3). For the honed subset in humans, both data files showed a predominant variant 
use of ATTAAA in testis when the canonical PAS in liver is used—and vice versa 
(Table 4; Table 5). 
Of the mouse sample, 34 transcripts out of the comprehensive 6341 transcripts 
were annotated (Table 6). Comparison of polyA-site use between tissues for the same 
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transcripts revealed 251 transcripts that use a different PAS in testis versus liver. 
Overall, transcripts in liver were more likely to use the canonical PAS (AATAAA) than 
testicular transcripts. In comparing alternative polyadenylation in both tissue types, 
transcripts in liver using the canonical PAS were most likely to use the alternative PAS: 
ATTAAA, with signals AGTAAA and TATAAA following up second (Table 7; Table 
8).  
Literature-mined transcripts were manually identified in the PolyA-seq data 
based on NCBI sequencing data (2007) and confirmed some transcript isoforms (Table 
9). Comprehensive transcripts from mouse testis and liver at the same polyA-site were 
annotated (Table 10). Table 11 depicts the honed subset generated and sorted to reflect 
descending gene expression. From the individually annotated tissue transcripts in 
mouse, 61 transcripts were identified from testis containing at least 2 isoforms—17 of 
which contained 3 or more transcript isoforms. From mouse liver tissue sample PolyA-
seq data, 83 transcripts were identified contained at least 2 transcript isoforms—19 of 
which contained 3 or more transcript isoforms as signified by variant polyA-site usage 
(Table 12). These transcripts isoforms were determined through a separate annotation 
(Table 13; Table 14).  
Gene ontology (GO) analysis was performed on the collective PolyA-seq data 
in mouse where transcripts were matched at the same genomic coordinate between the 
two tissue types (Table 15). Of the 6,341 transcripts matched in total, 34 were 
successfully annotated using the NCBI references files. GO terms associated with cell 
communication, cell cycle, and primary metabolic processes were overrepresented. 
Functional annotation included biological processes in ranked order: cellular process 
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(16.6%), of which include functions relating to cell communication and cell cycle; 
metabolic process (16.6%), including primary metabolic processes; localization 
(14.2%), dealing with RNA localization and transport; biological regulation (10.7%), 
developmental process (8.3%), relating to cell differentiation; response to stimulus 
(8.3%), cellular component organization or biogenesis (7.1%), immune system process 
(7.1%), multicellular organismal process (7.1%), apoptotic process (1.1%), biological 
adhesion (1.1%), and reproduction (1.1%), which encompasses gamete production.  
DISCUSSION 
In this study, available PolyA-seq data in testis and liver was mined and analyzed 
to determine if testis-specific APA transcripts or patterns of APA use could be 
identified. PolyA-seq data for mouse testis and liver was manually searched to compare 
reported PAS use with previously published transcripts to determine if PolyA-seq is a 
reliable predictor of tissue-specific PAS selection. For 50% of transcripts, PolyA-seq 
PAS, polyA-sites, and expression levels matched published 3’UTR isoforms identified 
from Northern blots (Table 9). For two transcripts (CPSF6 & DAZAP1), the PolyA-seq 
identified more PAS than had previously been found while for two other transcripts 
(DinB & TP1), where multiple isoforms have been validated, only one PAS was found 
(Table 9). 35% of the transcripts were not found in the PolyA-seq data, potentially 
identifying limitations to the poly(A)+ amplification method used to generate the cDNA 
libraries.    
Analysis of PAS selection at the same polyA-site between testis and liver did 
not reveal any differences in use; however, some transcripts use a different PAS at the 
same site. This would be expected due to genetic variation but the function of this 
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different PAS selection needs to be investigated. Findings from this analysis are 
complementary to previous reports of differential PAS use within the 3’UTR in 
individual male germ cells compared to somatic testicular Sertoli cells (Liu et al., 
1995).    
For human data, frequency of PAS use was not different between testis and liver 
at the same polyA-site. Transcripts in human data were identified that are expressed in 
both tissues but utilized a different PAS. Some of these transcripts were known to have 
a short 3’UTR in testis (e.g. CPSF6) while other transcripts are novel. GO analysis 
revealed that the majority of transcripts are involved in cell cycle regulation and cell 
communication, although it is difficult to draw direct implications from these results as 
the population annotated and processed through GO are less than 1% of the total 
transcripts. 
In total, 32 of the same transcripts were identified with isoforms in both testis 
and liver from mouse. These transcripts—which exist in both tissues—are involved in 
cell cytokinesis, cell signaling, and translation, suggesting that a fundamental core 
biological processes require ubiquitous gene expression. 
One limitation to this study is the incomplete reference files that were used to 
create the annotations. To date approximately 70% of the protein-encoding transcripts 
have been annotated—38% of which contain known RefSeq accession numbers. 
Furthermore, the methods of this analysis structured the available PolyA-seq data to the 
same polyA-site used within a margin for PAS comparisons. Future steps may include 
analyzing more completely annotated transcripts between and across tissue types for 
PAS usage. Further analysis can be conducted to: compare testis and liver for different 
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APA transcripts, more than one 3’UTR isoform in testis, and different 3’UTR isoforms 
in testis versus liver. Analyses may also consider exploring other tissue types to 
potentially identify tissue-specific APA characteristics. 
Potential steps to improve annotation endeavors include modifying the 
annotation VBA code to match PolyA-seq data to reference transcripts with only an 
upstream margin since any hits would only reflect the coding region product. 
Additionally, 3’UTRs have an average length of 800 nt in humans so extending the 




CHAPTER 3: METHOD REFINEMENT OF GERM CELL ISOLATION 
BY FLOW CYTOMETRY 
INTRODUCTION  
Successful development of male germ cells requires progression through 
different maturation stages (from spermatogonia, spermatocyte, spermatid and 
spermatozoa) and the support of testicular somatic cells including Sertoli and Leydig 
cells. Isolation of male germ cells from all developmental stages is essential for further 
investigation of cell-specific gene expression and regulation requires separation of the 
germ cell populations with minimal contamination from other germ cells or testicular 
somatic cells. Procedures to obtain relatively pure populations of spermatogonia, 
spermatocytes and spermatids have been developed but most are labor intensive and 
contamination from somatic cells remains. The use of developmental stages of the testis 
during the time of the emergence of the specific germ cell maturation stage is 
problematic, although widely used, due to the presence of other germ cell and somatic 
cell types (Bellve et al., 1977). Methods for obtaining only one cell type at the exclusion 
of others have focused primarily on spermatogonia stem cells by flow cytometry FACS 
separation detecting a stem cells specific antibody (Sun et al., 2011). STAPUT density 
gradients can be utilized to obtain isolated cells of different types from the same animal 
but this method yield relatively enriched populations but with cross-contamination from 
other cells and are highly sensitive to mechanical disruption (Liu et al., 2015; Bryant et 
al., 2013). A recent report of a centrifugation gradient that isolating relatively pure 
mouse germ cells requires access to a specialized rotor and can be prohibitive (Chang 
et al., 2011).     
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More recent flow cytometry protocols have facilitated the separation of 
relatively pure multiple germ cell populations from the same animal by utilizing the 
differences in DNA amount in different germ cell types. Spermatogonia are the only 
diploid germ cell population while meiotic spermatocytes contain double the DNA 
content (4N) and spermatids are haploid (1N).  Staining a suspension of germ cells with 
a DNA stain has been relatively successful in obtaining populations of spermatocytes 
and mixed stages of spermatids in the mouse (Bastos et al., 2005).  The current protocol 
requires fixation of the cells to allow for permeability of the Hoechst 33342 DNA stain 
to enter the cell membrane and bind to the DNA and is therefore prohibitive for 
downstream DNA and RNA isolation for further gene expression studies. Separation of 
live germ cell populations has been achieved with Hoechst 33342 but access to a FACS 
facility with a UV laser (needed to excite the dye) is not available in most flow 
cytometers. The goal of this research was to develop a method for separation of live 
germ cell populations using the DNA stain DRAQ5 that does not require a UV laser for 
excitation but more common air-cooled 488 nm laser.  
In this study, a mechanical and enzymatic digestion of testis was coupled with 
dual nuclear cell staining to isolate two populations of male germ cells, round 
spermatids and spermatocytes, using FACS. An advantage to this method is high yield 
of live cells that can be used in downstream RNA extraction and for further gene 
expression studies. Identity of the isolated germ cell populations was validated by germ 
cell expression by RT-PCR. Additionally, the ability to isolate multiple cell types from 
one mouse is both cost-effective and allows for decreased genetic variability for further 




Male Germ Cell Isolation  
 Male germ cell isolations from 6-8 week-old CD-1 strain mice were performed 
according to adapted published protocols (Getun, 2011). All male mice used in this 
study were purchased from Harlan Laboratories (Indianapolis, IN, USA) and protocols 
were approved by the URI Institutional Animal Care and Use Committee (protocol # 
AN07-05-029). Testes were collected and the tunica albuginea was removed. 
Decapsulated testes were placed into 15mL conical tubes and digested in Collagenase 
from 1 mg/mL Clostridium histolyticum (Sigma-Aldrich, St. Louis, MO, USA, cat# 
C5081), Gey’s Balanced Salt Solution (GBSS; Sigma-Aldrich, St. Louis, MO, cat# 
G9779) and 1 mg/mL DNase I Solution (Stem Cell Technologies, Vancouver, Canada, 
cat# 07900). At this point seminiferous tubules were visible in a cloudy solution. 
Conical tubes were manually agitated until testicular tubules started to dissociate. The 
tubes were then agitated horizontally at 120rpm for 15 minutes at room temperature on 
a Platform Vari-mix test tube rocker (Thermolyne; Thermo Scientific, Ashville, NC, 
USA). Tubes were left at room temperature for 15 minutes for phase separation. The 
supernatant was decanted into a new 15-mL conical tube. Here, spermatozoa along with 
populations of male germ cells, supporting cells, and debris were visible under light 
microscope. Digestion and agitation steps were repeated for both the pellet and 
supernatant with reagents only added to the pellet. Digestion steps were repeated again 
with the addition of 1mg/mL trypsin (Fisher Scientific, Pittsburg, PA, USA, cat# 
27250018) in 1mM HCl. The tubes were inverted to mix and then agitated horizontally 
at 120rpm for 15 minutes at room temperature. Any visible clumps were dissociated 
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using a plastic Pasteur pipette to mix for 3 minutes. Immediately following manual 
dissociation, fetal calf bovine serum (Sigma-Aldrich) was added to neutralize the 
trypsin. DNase I was added, tubes inverted to mix, and another round of digestion and 
agitation was performed using standard conditions. Samples were filtered through 
GBSS pre-wetted 20μM nylon net vacuum-driven filtration systems (Millipore 
Corporation, Billerica, MA, USA, cat# SCNY00020) and stored on ice. Following 
filtration, the final pellet solution shows little to no debris and cells with round 
morphology. 
Cell Purification by Flow Cytometry               
 Cells from pellet fractions were counted on the hemocytometer to determine the 
number of cells obtained, and stained with 5mM DRAQ5 (abcam, Cambridge, MA, 
USA, cat# ab108410)  and counter-stained with propidium iodide solution (PI; Sigma-
Aldrich, cat# P4864) according to manufacturer’s recommendations based on cell 
density. Target cells were then separated and quantified based on emission of DRAQ5 
(excitation wavelength: 647nm) and dead cell exclusion applied using propidium iodide 
solution (excitation wavelength: 535nm-617nm) on a BD Influx Cell Sorter (BD 
Sciences, Brown University, Providence, RI, USA). Live cell populations were gated 
into hypothesized meiotic spermatocytes and round spermatids and collected in 10% 
bovine serum albumin (BSA; Sigma-Aldrich)-covered 15mL conical tubes filled with 
TRIzol LS reagent (Life Technologies, Grand Island, NY, USA, cat# 10296028) to 
separate samples into RNA, DNA, and protein fractions. Collected samples suspended 
in TRIzol LS were incubated on ice in preparation for RNA extraction. 
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RNA Extraction and Isolation            
 RNA was extracted from the germ cell populations according to Life 
Technologies manufacturing protocol for TRIzol LS reagent (Chomczynski, 1993). 
RNA concentrations were determined and purity was verified for ideal 260/280 
absorbance ratio >1.8 by NanoDrop 8000 spectrophotometer (GSC Sequencing Center, 
University of Rhode Island, Kingston, RI, USA). Unused RNA were stored at -80°C. 
RT-PCR  
 RNA was reversed transcribed (RT) into cDNA using reagents and protocol 
from QuantiTect Reverse Transcription Kit (Qiagen, Hilden, Germany, cat# 205310) 
for use in polymerase chain reaction (PCR) amplification. Genomic DNA was 
eliminated in the RT reaction with gDNA Wipeout Buffer, template RNA, and RNase-
free water to volume. Samples were incubated for 2 minutes at 42°C and then reverse 
transcribed with Quantiscript Reverse Transcriptase, Quantiscript Buffer, and RT 
Primer Mix with incubation for 15 minutes at 42°C and 3 minutes at 95°C to inactivate 
Quantiscript Reverse Transcriptase. PCRs were performed under standard temperature 
condition: 94°C for 30 seconds, 35 cycles of 94°C for 30 seconds, primer-dependent 
annealing temperature for 30 seconds, 72°C for 2 minutes, and final extension for 10 
minutes at 72°C with 1X reaction buffer, 1.5mM MgCl2, 10mM dNTPs, 2.5μM gene-
specific forward and reverse primers, and 2.5U Taq polymerase (NEB, Ipswich, MA, 
M0273S). All PCRs were performed with a positive control with mouse testis cDNA, a 
negative control without template cDNA, and a negative control without enzyme. 
Amplified PCR products were run on a 2% agarose electrophoresis gel, purified and 
extracted (Qiagen QIAquick Gel Extraction Kit, cat# 28704), and submitted for 
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sequencing (URI Genome Sequencing Center). Sequenced amplicons were identified 
and verified using NCBI BLAST. cDNA was stored at -20°C.  
PCR Reactions  
 PCR reagents and manufacturer protocol from New England BioLabs (Ipswitch, 
MA) were used for gene amplification. Isolated populations of spermatocytes, round 
spermatids, and Sertoli cells and were verified for identity and purity using designed 
transcript-specific primers, including proto-oncogene (c-Kit, spermatogonia), 
synaptonemal complex protein 3 (SCYP3, spermatocytes), protamine 2 (PRM2, round 
spermatids), follicle-stimulating hormone (FSHR, Sertoli cells), and cholesterol side-
chain cleavage enzyme (P450scc, Leydig cells). Sample populations were tested to 
ensure absence of contamination. PCR products were separated by a 2% agarose gel 
electrophoresis, gene amplified band were captured using UV light to fluoresce 
ethidium bromide, bands were extracted for sequencing (URI Genomics and 
Sequencing Center), and verified with National Center for Biotechnology Information’s 
Basic Local Alignment Search Tool (NCBI BLAST).  
RESULTS 
 After mechanical and enzymatic disruption of the mouse testes and double 
staining with PI and DRAQ5, a representative FACS distribution of cells by size is 
shown in Figure 7 and Figure 8.  
Characterization of germ cell populations separated by flow cytometry  
The identity of the two germ cell populations, P1 & P2, were investigated by 
validated using germ cell-specific primers in RT-PCR (Table 18). The absence of 
testicular somatic Sertoli and Leydig cells were confirmed by the lack of amplification 
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of FSHR and p450scc respectively. Diploid spermatogonia were also not detected in 
these two populations. Positive amplification of SYCP3 in the P2 population, but lack 
of amplification in the P1 population, indicated that this population with the highest 
fluorescence intensity included 4N spermatocytes. Population P1 contained haploid 
round spermatids as indicated by the amplification of PRM2 and Dbil5.   
DISCUSSION 
A protocol for FACS isolation of live round spermatid and spermatocytes from 
adult male mice was developed using the nuclear stain DRAQ5. Purified live cells may 
be used in further downstream molecular biology applications, including RNA 
extraction and PCR. In total, this method takes roughly two and a half hours to prepare 
the cells, an additional three hours to sort cells by FACS, and additional time for post-
sort manipulations.  
Further modifications of the protocol are necessary to isolate the diploid 
spermatogonia germ cells in addition to the somatic Sertoli and Leydig cells. The 
FSC/SSC cell distribution with DRAQ5 did not demonstrate as many distinct cell 
populations as previously published in fixed cells populations stained with Hoescht 
33342. Diploid cells may have been lost in the digestion and filtration steps prior to 




CHAPTER 4: PRODUCTION OF THE POLYA-SEQ LIBRARIES FROM 
ISOLATED MALE GERM CELL POPULATIONS 
 
INTRODUCTION 
PolyA-seq is a robust method of sequencing polyA-site use and determining 
3’UTR length in different tissues (Derti et al., 2012). Previous PolyA-seq studies have 
sequenced polyA+ RNA from whole testicular tissue, including germ cells and somatic 
cells. The bioinformatics analysis described in Chapter 2 is from testis PolyA-seq and 
is a mix of germ cells and somatic testicular cells (Sertoli cells, Leydig cells and 
peritubular cells). The inclusion of somatic tissue may mask the germ cell specific gene 
expression patterns, making a male germ cell specific pattern of PAS use and 
identification of transcripts with a short 3’UTR difficult to examine. Based on the 
method of PolyA-seq library preparation (Derti et al., 2012), sequencing libraries for 
the isolated germ cell populations separated by DRAQ5 were developed as described in 
Chapter 3. Briefly, generation of these libraries involved isolating poly(A)+ mRNA from 
male germ cell total RNA, attaching a d(T) primer to specifically target the PAS and 
polyA-site, PCR amplification and purification, and gel electrophoresis to visualize the 
product size.  
METHODS 
 cDNA libraries were generated from two populations of male germ cells (P1 & 
P2) that were separated by DRAQ5 (Chapter 3). After RNA isolation from Trizol as 
described in Chapter 3, poly(A)+ RNA was isolated from the total RNA using the 
Oligotex mRNA Mini Kit (Qiagen,  cat# 70022 ). 150 ng poly(A)+ RNA from each cell 
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type was reverse transcribed using a T10VN (ten thymidine and non-thymine nucleotide 
attached to a random base) primer and second strand synthesis completed with random 
hexamer-PCR anchor primers. U1 and U2 have sequence complementary to Illumina-
specific adapters which were added through a nested PCR to maintain strand-specificity 
and cDNA were fragmented for sequencing. Single-end sequencing in parallel was 
attempted for the prepared spermatocyte (n=2), round spermatid (n=2) PolyA-seq 
cDNA libraries at LC Sciences (Houston, TX), but was unsuccessful. 
RESULTS 
Poly(A)+ mRNA was isolated from spermatocyte (P1) and round spermatid (P2) 
total RNA for PolyA-seq library preparation, which required 100ng input RNA. Yields 
from the poly(A)+ enrichment are shown in Table 18. Based on the low poly(A)+ RNA 
yields, the individual germ cell populations were pooled to make the PolyA-seq libraries 
that contained only spermatid and spermatocyte male germ cells with biological 
replicates isolated by FACS on two separate days. Whole testis and liver, used as a 
somatic tissue control, PolyA Seq libraries were also generated (Figure 8). 
DISCUSSION 
PolyA-seq libraries were generated from round spermatids, spermatocytes, 
pooled spermatids and spermatocytes, liver, and whole testis tissues. Only one library 
each from the spermatids and spermatocytes could be generated due to the low yield of 
poly(A)+ mRNA. Several more runs of FACS isolation of cells are needed to generate 
enough poly(A)+ mRNA to potentially be more successful.  
Due to the low yield of poly(A)+ mRNA, sorted round spermatid and 
spermatocyte populations were combined to make a library that contained only male 
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germ cells. These were more successful due to the larger amount of starting poly(A)+ 
mRNA. Unfortunately, these libraries would not be sequenced.  
It is worth-while to note that about 80% of total RNA from mammalian cells is 
ribosomal RNA (rRNA). This leaves the remainder comprised of transfer RNA 
(tRNA) and about 2-3% polyA+ mRNA (Lodish et al., 2000). Furthermore, RNA is 
susceptible to degradation by RNases. Based on these results and background 
information, it is recommended to sort for 100,000 events by FACS to yield 2,500µg 
total RNA, which should yield approximately 1µg poly(A)+ mRNA for library 
generation. Prior to enrichment of polyA+ mRNA, total RNA should be evaluated for 
quality and the absence of degradation. Running extracted total RNA on a 1% agarose 
gel should yield crisp bands for 28S rRNA that is twice the intensity of lower 18S 
rRNA. Equal rRNA band intensities or mRNA smearing below the rRNA bands 
indicate poor quality of RNA that should not be used for polyA+ mRNA isolation. 
Bioanalyzers may also be used to measure rRNA band sizes and will produce an RNA 
Integrity Number used to quantify RNA quality from RIN 10, representing intact 









Germ Cell Isolation for Flow Cytometry Protocol with DRAQ5 
 
Supplies Needed— 
15mL tube (x6) 
Gey’s Balance Salt Solution (GBSS) 
Collagenase type I 
DNase I (x3   50μL aliquots) 
Trypsin  
Fetal Calf Serum 
Aluminum foil 
Propidium Iodide  
5mL plastic syringe 
Plastic Pasteur pipette (x8) 
Millipore Conical Tube Filter (x2) 
50mL conical tube/Isoflurane 
              DRAQ5 
 
Solution to prepare—  
 GBSS + Collagenase Mixture (GBSS/Col): 
              25mg Collagenase 
              25mL GBSS 
 
Part I: Testis Preparation 
 
1. Place one decapsulated testis in a 15mL tubes, 2 tubes: 1 for each testis 
2. Add to each tube: 3mL GBSS/Col 
                             10μL DNase I  
3. Shake vigorously by hand until testicular tubules start to dissociate.  
4. Agitate horizontally at 120rpm for 15 mins at room temperature. 
5. Let sit for 1 minute, then decant supernatant off into separate tube, keep using 
all tubes (4). 
6. Repeat steps 2-4, adding more reagents to the pellet tubes only. 
7. Let sit for 15 minutes at room temperature, if pellet forms, decant off the 
supernatant! 
8. Add to each tube: 2.5mL GBSS/Col 
                 50μl Trypsin  
    10μl DNase I  
9. Invert tube several times to mix. Agitate horizontally at 120rpm for 15 mins at 
33°C. 
10. Pipette up and down gently using plastic Pasteur pipette for 3 min. No clumps 
should be visible. 
11. Add to each tube: 30μl Trypsin 
 10μl DNase I   
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12. Invert tube several times to mix. Agitate horizontally at 120rpm for 15 mins at 
33°C. 
13. Add to all tubes: 400μL fetal calf bovine serum (FCS), invert tubes to mix. 
10μL DNase I  
14. Pass samples through GBSS pre-wetted filters. Wrap all tubes in aluminum 
foil. 
15. Hemocytometer count. See Part II. 
16. Add to selected tubes: 5μl propidium iodide (PI) solution 
            DRAQ5 (amount based on hemocytometer count) 
Part II: Hemocytometer Count 
 
1. Transfer 10μl of sample into hemocytometer on both sides. (If too much 
overlap, dilute sample.) 
2. Count all 5 squares within triple lines. 
3. Take total count in square * 50,000 → number of cells/mL. Dilute solution 
with GBSS if needed. 
4. Add appropriate amount of DRAQ5 according to chart and allow to sit at room 
temperature for 5-30 minutes before processing through flow cytometer.  
 
Part III: Samples and Reagents to Sort on Flow 
 
1. DRAQ5 + PI Stained 
2. DRAQ5 Only 
3. PI Only 
4. Unstained & extra dye (DRAQ5 & PI) 
5. Trizol LS Tubes (1.5mL)  
 





RNA Isolation Protocol for Male Germ Cells 
 
Part I: Phase Separation 
1. Add 200μL chloroform per 750μL of TRIzol LS in microcentrifuge tubes and 
shake vigorously for 15 seconds. 
2. Let tubes sit at room temperature for 15 minutes.  
3. Centrifuge at 12,000 x g for 15 minutes at 4°C. 
4. Remove and keep clear aqueous phase (top layer) in new tubes.  
 
Part II: RNA Precipitation 
1. Add 2μL glycogen to each sample. 
2. Add 500μL isopropanol and let samples sit for 15 minutes in -20°C. 
3. Centrifuge at 12,000 x g for 15 minutes at 4°C. 
 
Part III: RNA Wash and Resuspension 
1. Keep samples on ice!  
2. Remove supernatant from tube, leaving only RNA pellet.  
(If there is no visible pellet, keep supernatant in conical tubes and leave a 
layer of liquid where pellet is estimated to be.) 
3. Wash the pellet with 1mL 75% ethanol and leave in -20°C overnight. 
4. Centrifuge sample at 7500 x g for 10 minutes at 4°C and discard the  
supernatant. 
5. Air dry samples on ice for 10 minutes. 
6. Add 25μL RNase-free water and pipette to mix and dissolve pellet. 






Reverse Transcription (RT) – Qiagen QuantiTect Version Protocol  
 
1. Mix together: 
Reagent Volumes per Reaction 
gDNA Wipeout Buffer, 7x → 2µL 
Template RNA → variable (up to 1µL) 
RNase-free water → to total volume of 14µL 
2. Incubate for 2 minutes at 42ºC then immediately place on ice.  
3. Add: 
Reverse Transcriptase → 1µL 
RT Buffer, 5x → 4µL 
RT Primer Mix → 1µL 
4. Incubate for 15 minutes at 42ºC. 
5. Incubate for 3 minutes at 95ºC to inactivate Reverse Transcriptase. 
6. Hold at 4ºC. 






Polymerase Chain Reaction (PCR) Protocol 
 
Samples 
a. cDNA from RT reaction 
b. RT negative control: no enzyme 
c. PCR negative control: no template RT added 
 
Reagents 
Standard Taq Buffer → 5µL 
Forward Primer → 4µL 
Reverse Primer → 4µL 
MgCl2 → 3µL 
dNTPs → 1µL 
Taq polymerase → 0.5µL 
diH2O → 31.5µL 
cDNA template → 1µL  
 
Thermocycler conditions 
1 cycle: 94ºC for 3 minutes 
35 cycles: 94ºC for 30 seconds, ____ºC for 30 seconds, 72ºC for 30 seconds 
1 cycle: 72ºC for 10 minutes 




NEBNext Oligo d(T)25 Magnetic Beads mRNA Isolation Protocol 
 
Supplies Needed—0.2mL PCR tubes 
RNA sample 
NEBNext Magnetic Oligo d(T)25 Beads & Kit 
Tris Buffer 







Starting Material: 1–5 µg of total RNA.  
 
1. Dilute total RNA with nuclease-free water to a final volume of 50μl in a PCR 
tube.  
2. Add to a new PCR tube: 15μl NEBNext Magnetic Oligo d(T)25 Beads  
3. Wash beads two times with 100μl RNA Binding Buffer. Pellet with magnet 
and discard supernatant.  
4. Resuspend beads in 50μl RNA Binding Buffer and add to tube: 50μl total 
RNA sample from step 1. 
5. Place the tubes in thermocycler for conditions: 65°C for 5 minutes, hold at 4°C 
to denature the RNA and facilitate binding of the poly-A-RNA to the beads 
and remove sample. 
6. Place the tubes on the bench and incubate at room temperature for 5 minutes to 
allow the RNA to bind to the beads. 
7. Place the tubes on the magnetic rack at room temperature for 2 minutes to 
separate the poly-A RNA bound to the beads from solution. 
8. Remove and discard all supernatant. Do not disturb beads! 
9. Remove the plate from the magnetic rack.  
10. Wash the beads twice with 200μl Wash Buffer to remove unbound RNA. 
Pipette the up and down 6 times to mix. 
11. Place the tubes on the magnetic rack at room temperature for 2 minutes.  
12. Remove and discard all supernatant from each well of the plate using a 
multichannel pipette. Do not disturb beads! 
13. Remove tubes from the magnetic rack. 
14. Add 50μl Tris Buffer to each well of plate. Gently pipette up and down 6 
times to mix. 
15. Place the tubes in thermocycler for conditions: 80°C for 2 minutes, hold at 
25°C for sample removal. 
16. Add 50μl RNA binding buffer to each sample to allow RNA to bind to beads. 
Gently pipette up and down 6 times. 
17. Incubate the tubes at room temperature for 5 minutes.  
18. Place the tubes on the magnetic stand at room temperature for 2 minutes.  
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19. Remove and discard all of the supernatant from each tube. Do not disturb 
beads! 
20. Remove the tubes from magnetic stand.  
21. Wash the beads twice with 200μl Wash Buffer. Gently pipette up and down 6 
times. 
22. Place the tubes on magnetic stand at room temperature for 2 minutes.  
23. Remove and discard all supernatant from each tube. Do not disturb beads! 
24. Remove tubes from magnetic stand. 
25. Elute the mRNA from the beads by adding 17µl Tris Buffer and incubating 
sample at 80°C for 2 minutes. Immediately place tubes on magnetic rack.  
26. Collect purified mRNA by transferring the supernatant to a clean PCR tube.  
27. Place tube on ice and nanodrop. 
  
Thermocycler Conditions 
65°C: 5 minutes 
Hold: 4°C  
80°C: 2 minutes 
Hold: 25°C  
80°C: 2 minutes 














Superscript III Reverse Transcriptase 
RNase H 
10X NE Buffer 2 
Klenow Enzyme 
 MgCl2 
Roche HF Enzyme Mix 




1. Heat microcentrifuge tube with nuclease-free elution water to 55°C for part II.  
2. Reconstitute primers to 50μM and 10μM. TB1003 primer will be reconstituted 
from 50μM to 0.1μM. 
 
Part I: First Strand Synthesis Reaction (Invitrogen) 
 
1. Add and mix following in a PCR strip tube:  
x μl polyA + RNA (100ng) 
2μl TB1003 primer (0.1μM) ** 
**[Add 656μl of primer water to blue top to reach 50μM. Then 1μl of 
50μM + 499μl primer water.] 
2. Bring volume to 11.4μl with water. 
3. Heat to 65°C for 10 minutes and hold at 4°C. 
4. Add and mix following in PCR strip tube: 
4μl 5X buffer (Invitrogen) 
1.6μl dNTPs (25mM)  
1μl DTT 
1μl RNase OUT (Invitrogen) 
1μl Superscript III Reverse Transcriptase (Invitrogen) 
5. Incubate at 40°C for 90 minutes, 70°C for 15 minutes, and cool to 4°C. 
6. Add to tube and mix: 1μl RNase H (Invitrogen) 
7. Incubate at 37°C for 20 minutes, 75°C for 15 minutes, and cool to 4°C.  
 
Part II: First Qiagen Purification 
Add and mix 79μl water. 
Add 500μl buffer PB and pass over qiaquick at 13,000g for 1 minute. 
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 Wash with 750μl wash buffer and spin at 13,000g for 2 minutes. 
In new microcentrifuge tube, elute twice with 30μl elution water (55°C from 
preparation step).  
Let sit for 1 minute before spinning at 13,000g for 2 minutes.  
 
Part III: Second Strand Synthesis Reaction 
1. Add 40μl of Second Strand mix (below) to 1st strand product (60μl from 
above) in a PCR tube: 
11.7μl water 
10μl 10XNE Buffer 2 
10μl TB-rev (GA) - 10μM 
5μl 10mM dNTPs 
3.3μl Klenow enzyme (5U/μl of NEB exo’ Klenow #M0212L) 
2. Incubate at 37°C for 30 minutes in thermocycler. 
 
Part IV: Ampure XP-Purification 
1. Add 180μl Agencourt AMPure XP Beads and let sit for 5 minutes at room 
temperature. 
2. Separate supernatant using magnetic rack and discard supernatant.  
3. Wash twice with 70% EtOH. Remove as much as possible on magnetic stand 
and dry off residual EtOH on ice.  
4. Elute with 50μl elution buffer. 
5. Nanodrop to check for DNA concentration. 
 
Part VI: PCR 
1. In new PCR tube, add 31μl of purified Second Strand Synthesis product to 
18μl of PCR mix: 
10μl 10X Buffer (Roche Reagent #2) 
2.5μl 99.9% DMSO  
1μl 10mM dNTP 
2μl 10μM TB1007 primer 
2μl 10μM TB 1002 primer 
1μL 25mM MgCl2 (Roche Reagent #4) 
2. Add to each tube 0.5μl Roche HF Enzyme Mix at 4°C and mix by pipette.  
2. Amplify using conditions: 
2 Cycles— 
94°C for 10 seconds 
40°C for 2 minutes 
72°C for 1 minute 
 
8 Cycles— 
94°C for 10 seconds 
60°C for 30 seconds 





94°C for 15 seconds 
60°C for 30 seconds 
72°C for 1 minute + 10 seconds 
 
72°C for 5 minutes  
4°C hold 
 
Part VII: Second Ampure Purifucation 
1. Add 90μl Agencourt AMPure XP Beads and let sit for 5 minutes at room 
temperature.  
2. Wash twice with 70% EtOH. 
3. Elute with 50μl elution buffer. 
 
Part VIII: Post PCR Analysis 
1. Nanodrop. 
2. Run PCR reaction out on gel. Should see band ranging from ~80-250nt. 
 
Part VIV: Sequencing 






Step 1 VBA: Delete Rows with Same PAS 
 
*Note: This code is written in Visual Basic for Applications (VBA) for Excel macro 
development. Any line that starts with an apostrophe indicates a comment. 
 
Sub remove() 
  Dim sr1 As Long 
  'This code works with the assumption that you have the first row as a header. 
  'If there is no header, just add in a blank row. 
  'Active sheet for this was written as "Sheet4".  
  'This sheet name can be changed or you can re-name your sheet to match the code. 
   
  'MISC. NOTES & DIRECTIONS 
  'For easier visualization check purposes, I choose to perform is TRUE/FALSE 
function before running this. 
  'In Excel, go to the "Formula" tab --> "Text" --> "EXACT".  
  'Select your two cells of polyadenylation signals (PAS) to compare.  
  'Carry out this function to the reminder of the column(s).  
  'If your PAS match, in a new column "TRUE" will print. If they differ, "FALSE" will 
print. 
  'Run code. This will delete all rows where PAS are the same, leaving you with a 
bunch of "FALSE"s.  
  'Check the last two rows once the code has finished.  
  'This isn't perfect so you might have to manually delete the last two if they're 
matching. 
   
  For sr1 = 2 To Sheets("Sheet4").Range("D3").CurrentRegion.Rows.Count - 1 
          If Sheets("Sheet4").Cells(sr1, 4).Value = Sheets("Sheet4").Cells(sr1, 5).Value 
Then 
              Sheets("Sheet4").Rows(sr1).EntireRow.Delete 
              Exit For 
          End If 




















Dim CurrentRow, EndsAt, Progress, NumOfRows As Long 
Dim DataSheet, CurrentChrNum, CurrentGeneLong, CurrentID, CurrentGeneShort As 
String 
 
CurrentRow = 1 




NumOfRows = Selection.Rows.Count 
Cells(1, 1).Select 




Progress = 0 
OnePercent = 100 * Round(NumOfRows / 10000) 
HowManyKs = Left(NumOfRows, Len(Str(NumOfRows)) - 4) 
     
'FIND THE CHROMOSOME # 
For i = 1 To 100 
    If InStr(Cells(i, 1).Value2, "DEFINITION") > 0 Then 
       
      If InStr(Cells(i, 1).Value2, "unplaced") > 0 Then 
            CurrentChrNum = "ChrUn" 
          Exit For 
      End If 
      '                                       37 for humans   VV   52 for mice 
      CurrentChrNum = "chr" & Replace(Mid(Cells(i, 1).Value2, 52, 2), " ", "") 
      Exit For 
    End If 
Next i 
     
MsgBox ("Processing data for " & CurrentChrNum & ". It has " & NumOfRows & " 
rows. If either of those are wrong, do a manual fix in the code.") 
'NumOfRows = if it's not correct, then write the actual number here 
'CurrentChrNum = if it's not correct, then write the actual chr# here. Format, for 
example: chr1, chr2, chr10, chr18, chrX, chrUn 
     
'CREATE NEW WORKSHEET CALLED CHR# 
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Sheets.Add.Name = CurrentChrNum 
 
'CHANGE THE ACTIVE SHEET BACK TO THE ONE WITH DATA 
Sheets(DataSheet).Activate 
 
'START EXTRACTING DATA 
For i = 1 To NumOfRows 
    'This looks for mRNA, or misc_RNA, and also for numbers because those 
keywords appear randomly as well. 
    If (InStr(Cells(i, 1).Value2, "misc_RNA") + InStr(Cells(i, 1).Value2, "mRNA") > 
0) Then 
        If (HaveNumbers(Cells(i, 1)) = True And InStr(Cells(i, 1).Value2, "..") > 0) Then 
         
        Cells(i, 2).Value2 = "X" 'for debugging only, can be deleted 
         
    'ID 
    For iplus = 1 To 150 
    Where = InStr(Cells(i + iplus, 1), "/transcript_id=") 
    If Where > 0 Then 
      CurrentID = Mid(Cells(i + iplus, 1), Where + 16, Len(Cells(i + iplus, 1)) - Where - 
16) 
      Cells(i, 3).Value = CurrentID 'for debugging only, can be deleted 
      Exit For 
    End If 
    Next iplus 
    iplus = 0 
    j = 0 
     
    'SHORTNAME 
    For iplus = 1 To 150 
    Where = InStr(Cells(i + iplus, 1), "/gene=") 
    If Where > 0 Then 
      CurrentGeneShort = Mid(Cells(i + iplus, 1), Where + 7, Len(Cells(i + iplus, 1)) - 
Where - 7) 
      Cells(i, 4).Value = CurrentGeneShort 'for debugging only, can be deleted 
      Exit For 
    End If 
    Next iplus 
    iplus = 0 
    j = 0 
     
     
    'LONGNAME 
    For iplus = 1 To 150 
    Where = InStr(Cells(i + iplus, 1), "/product=") 
    If Where > 0 Then 
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      CurrentGeneLong = Mid(Cells(i + iplus, 1), Where + 10, Len(Cells(i + iplus, 1)) - 
Where) 
       
      For j = 1 To 20 
        If InStr(Cells(i + iplus + j, 1), "         /") > 0 Then 
            Do Until InStr(CurrentGeneLong, "  ") = 0 
               CurrentGeneLong = Replace(CurrentGeneLong, "  ", " ") 
               If Right(CurrentGeneLong, 1) = Chr(34) Then CurrentGeneLong = 
Replace(CurrentGeneLong, Chr(34), "") 
            Loop 
            Exit For 
        End If 
        CurrentGeneLong = CurrentGeneLong & Cells(i + iplus + j, 1) 
      Next j 
      If Right(CurrentGeneLong, 1) = Chr(34) Then CurrentGeneLong = 
Replace(CurrentGeneLong, Chr(34), "") 
      Cells(i, 5).Value = CurrentGeneLong 'for debugging only, can be deleted 
      Exit For 
    End If 
    Next iplus 
    iplus = 0 
    j = 0 
     
     
    'INTERVALS 
    'If it finds them, looks for the intervals. 
      Do 
        'Some of them are in multiple cells, so this'll keep checking until it finds a ) 
        For j = 1 To Len(Cells(i + iplus, 1)) 
          Select Case Mid(Cells(i + iplus, 1), j, 1) 
                 Case 0 To 9 
                    Sheets(CurrentChrNum).Cells(CurrentRow, 2 + EndsAt).Value = 
Sheets(CurrentChrNum).Cells(CurrentRow, 2 + EndsAt).Value & Mid(Cells(i + iplus, 
1), j, 1) 
                 Case "." 
                    EndsAt = 1 
                 Case "," 
                    EndsAt = 0 
                     
                    Sheets(CurrentChrNum).Cells(CurrentRow, 1).Value = CurrentChrNum 
                    Sheets(CurrentChrNum).Cells(CurrentRow, 4).Value = CurrentID 
                    Sheets(CurrentChrNum).Cells(CurrentRow, 5).Value = CurrentGeneShort 
                    Sheets(CurrentChrNum).Cells(CurrentRow, 6).Value = CurrentGeneLong 
                    CurrentRow = CurrentRow + 1 
           End Select 
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        Next j 
        
        iplus = iplus + 1 
      Loop Until InStr(Cells(i + iplus, 1).Value2, "/") > 0 
      Sheets(CurrentChrNum).Cells(CurrentRow, 1).Value = CurrentChrNum 
      Sheets(CurrentChrNum).Cells(CurrentRow, 4).Value = CurrentID 
      Sheets(CurrentChrNum).Cells(CurrentRow, 5).Value = CurrentGeneShort 
      Sheets(CurrentChrNum).Cells(CurrentRow, 6).Value = CurrentGeneLong 
      CurrentRow = CurrentRow + 1 
      EndsAt = 0 
    iplus = 0 
    j = 0 
     
    End If 
    End If 
     
'TO CHECK LATER IF THE CODE FAILED TO FIND ANYTHING 
CurrentID = "MISSINGDATA" 
CurrentGeneShort = "MISSINGDATA" 
CurrentGeneLong = "MISSINGDATA" 
'PROGRESSBAR UPDATE 
Progress = Progress + 1 
If Right(Progress, 2) = "00" Then 
    Progresshundreds = Progresshundreds + 1 
    If Progress = OnePercent Then 
        MakingProgress.ProgressBar.Width = Round(200 * i / NumOfRows) 
        MakingProgress.ProgressText.Caption = Round(100 * i / NumOfRows) & "%" 
        Progress = 0 
    End If 
    MakingProgress.Caption = Format(Progresshundreds / 10, "#.0") & "k/" & 
HowManyKs & "k lines processed." 
    DoEvents 







'TAKES THE DATA, AND COPIES IT INTO A NEW FILE FOR LATER 
PROCESSING 
Application.DisplayAlerts = False 
ThisWorkbook.Sheets(DataSheet).Delete 




If Dir(ThisWorkbook.Path & "\processed", vbDirectory) = "" Then MkDir 
ThisWorkbook.Path & "\processed" 
ExportTo.Sheets(2).Delete 
Application.DisplayAlerts = True 
Application.ScreenUpdating = False 
ExportTo.Sheets(1).Columns("A:F").Sort key1:=Range("B1"), _ 
      order1:=xlAscending 
Application.ScreenUpdating = True 
ExportTo.SaveAs Filename:=ThisWorkbook.Path & "\processed\" & CurrentChrNum, 
FileFormat:=50 
ExportTo.Close 





Function HaveNumbers(oRng As Range) As Boolean 
'Source: http://stackoverflow.com/questions/18906581/how-can-i-check-if-a-cell-in-
excel-spreadsheet-contains-number 
     Dim bHaveNumbers As Boolean, k As Long 
     bHaveNumbers = False 
     For k = 1 To Len(oRng.Text) 
         If IsNumeric(Mid(oRng.Text, k, 1)) Then 
             bHaveNumbers = True 
             Exit For 
         End If 
     Next 








Step 3 VBA: Annotate Data 
 
Sub Step3AnnotateData() 
Dim chrNumOfRows, NumOfRows, StartAt, NumOfMatches As Long 
Dim Progress As Double 
Dim CurrentlyOpen, DataSheet, DataWkbk As String 
Dim WhichColor, Previous As Integer 
 
'COLOR SETUP 
'Set up some arrays for the colors. These are used later visually separate blocks of 
annotated transcripts.  
R = Array(255, 181, 154, 193, 134, 251) 
G = Array(250, 225, 206, 179, 207, 182) 
B = Array(129, 174, 223, 215, 190, 209) 
WhichColor = 0 
 
'COUNTS ROWS 
'NumOfRows: Length of DataToMatch. Counting the rows will tell the program how 
to loop.  




'Shows the ProgressBar2 UserForm.  
MakingProgress2.Show vbModeless 
Progress = 0 
 
'OTHER PREPARATIONS 
'Sorts the chromosome in ascending order to streamline annotating.  
Application.ScreenUpdating = False 
ThisWorkbook.ActiveSheet.Columns("A:H").Sort key1:=Range("a1"), _ 
        order1:=xlAscending, key2:=Range("b1"), order2:=xlAscending 
Application.ScreenUpdating = True 
 
'SAVE THE NAMES 
'We'll be switching back and forth between the data to match, and the chr# files, so 
again, just to be safe, everything is stored in strings. 
DataSheet = ActiveSheet.Name 
DataWkbk = ThisWorkbook.Name 
 
NumOfMatches = 0 




'CREATE NEW SHEET 
'Creates a new sheet to save the annotations. Default named: "Matches". To avoid 
errors, make sure there isn't already an existing sheet named "Matches." 
Workbooks(DataWkbk).Sheets.Add.Name = "Matches" 
 
'DEFINING VARIABLES 
'To define some variables: Workbooks(DataWkbk).Sheets(DataSheet) = this refers to 
the mouse/human data file that we're looping through. 
'In this file: Cells(i, 1) = chr1, chr2, chr3, and so on where "i" refers to the row index 
and the number refers to the column index. 
'Important: the variable CurrentlyOpen will always get this value, because that's the 
file it needs to open. 
'Cells(i, 2) = Testis number | Cells(i, 3) = Liver number | Cells(i, 4-5-6) = other data 
'Workbooks(CurrentlyOpen & ".xlsb").Sheets(CurrentlyOpen) = is the chr# file we 
currently have open to go through looking for matches. 
'The structure of the other file is basically the same: 1st column: chr#, 2nd: testis data, 
3rd: liver data, 4-5-6th: misc data. 
 
'MAIN LOOP STARTS 
'It runs until we get to the end of the file (meaning i = the number of rows it needs to 
go through). 
'You'll see this condition at the very end of the code in a row starting with "Loop 
Until". Watch the #####s! 
Do 
 
CurrentlyOpen = Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 1).Value2 
'MsgBox (i & "  Opening " & Workbooks(DataWkbk).Path & "\processed\" & 
CurrentlyOpen & ".xlsb") 
Application.ScreenUpdating = False 
 
'OPEN FILE 
'This (because of the nested loop) is only called again, if the chr# changes. 
'The Dir() command checks if the specified file path exists. If it equals "", then it does 
NOT.  
If Dir(Workbooks(DataWkbk).Path & "\processed\" & CurrentlyOpen & ".xlsb") = "" 
Then 
    Workbooks.Open (Workbooks(DataWkbk).Path & "\processed\" & "chrM.xlsb") 
    CurrentlyOpen = "chrM" 
    Else: Workbooks.Open (Workbooks(DataWkbk).Path & "\processed\" & 
CurrentlyOpen & ".xlsb") 
End If 
Application.ScreenUpdating = True 
 
'Another file length count, but this time it's the chr# file. 
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'***** 1ST NESTED LOOP ***** starts 
'A new file will only need to be opened if the next row's chr# is different from the 
current one. 
'Again, you can see this later when this loop ends in a row starting with "Loop Until". 




'This code will check the values at every 2% of the file, and start the loop when we're 
close enough. 
 
'FIND WHERE TO START LOOKING 
For j = 1 To 50 
 
'IF[              current liver data value                ] >= [                             chr# file, 2-4-
6%th row liver data value                                  ] 
If Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 2).Value2 >= 
Workbooks(CurrentlyOpen & ".xlsb").Sheets(CurrentlyOpen).Cells(1 + Round((j - 1) 
* chrNumOfRows / 50), 2) Then 
    'This might produce a false negative if the matches are in the last 2%, so just in 
case: 
    If j = 50 Then StartAt = Round(chrNumOfRows * 0.98) - 100 
    '-100 in case the 2%-th cell is in the middle of identical matches (variants, for 
example) 
   'IF [              current liver data value                ] >= [                             chr# file, 4-6-
8%th row liver data value                              ] 
    If Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 2).Value2 <= 
Workbooks(CurrentlyOpen & ".xlsb").Sheets(CurrentlyOpen).Cells(1 + Round((j) * 
chrNumOfRows / 50), 2) Then 
         
        'We only get here if we found the interval of our matches. 
        StartAt = Round(chrNumOfRows / 50 * (j - 1)) - 100 
         
        Exit For 




If StartAt < 1 Then StartAt = 1 
' FOUND WHERE TO START LOOKING 
 
Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 9).Value2 = "No Matches" 
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Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 10).Value2 = StartAt 
'Now we know where we should start looking. 
 
j = 0 
 
' MATCH FINDING starts 
'This starts looking for matches where it seemed optimal to do so, and will keep 
looking for them until the supposedly matching liver data have a difference larger than 
100bp between them. (Note: if you want to change the bp margin, just change this 
number.) You'll see this condition, again, lower down when the row says "Loop 
Until". Look for the &&&&&s! 
 
Do 
If Abs(Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 2).Value2 - 
Workbooks(CurrentlyOpen & ".xlsb").Sheets(CurrentlyOpen).Cells(StartAt + j, 
2).Value2) <= 100 Then 
    If Abs(Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 3).Value2 - 
Workbooks(CurrentlyOpen & ".xlsb").Sheets(CurrentlyOpen).Cells(StartAt + j, 
3).Value2) <= 100 Then 
    'Abs() gives you the absolute value of something. Basically what we're calculating 
here: 
    'If Abs(liver data - chr file liver data) is <= 100 then If Abs(testis data - chr file 
testis data) is <= 100 then we have a match! 
    'We start the search at the StartAt row, we use j to loop until the difference is 
greater than 100. If either of the Ifs fail, we jump straight to the next j. 
     
        'We have a match! 
    NumOfMatches = NumOfMatches + 1 
    Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 9).Value2 = "Match!"  
     
    'The coloring just serves as a way to separate different genes from the next.  
    If (NumOfMatches > 1 And Previous <> i) Then 
        If Workbooks(DataWkbk).Sheets("Matches").Cells(NumOfMatches, 1).Value2 
<> Workbooks(DataWkbk).Sheets("Matches").Cells(NumOfMatches - 1, 1).Value2 
Then 
        WhichColor = WhichColor + 1 
        Workbooks(DataWkbk).Activate 
        If WhichColor = 5 Then WhichColor = 0 
    End If 
    End If 
        'We found a match. This takes all the data attached to it and put it in a new row in 
our Matches sheet. 
    Workbooks(DataWkbk).Sheets("Matches").Rows(NumOfMatches).Interior.Color = 
RGB(R(WhichColor), G(WhichColor), B(WhichColor)) 
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    Workbooks(DataWkbk).Sheets("Matches").Cells(NumOfMatches, 1) = 
CurrentlyOpen 
    Workbooks(DataWkbk).Sheets("Matches").Cells(NumOfMatches, 2) = 
Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 2) 
    Workbooks(DataWkbk).Sheets("Matches").Cells(NumOfMatches, 3) = 
Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 3) 
    Workbooks(DataWkbk).Sheets("Matches").Cells(NumOfMatches, 4) = 
Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 4) 
    Workbooks(DataWkbk).Sheets("Matches").Cells(NumOfMatches, 5) = 
Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 5) 
    Workbooks(DataWkbk).Sheets("Matches").Cells(NumOfMatches, 6) = 
Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 6) 
    Workbooks(DataWkbk).Sheets("Matches").Cells(NumOfMatches, 7) = 
Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 7) 
    Workbooks(DataWkbk).Sheets("Matches").Cells(NumOfMatches, 8) = 
Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 8) 
    Workbooks(DataWkbk).Sheets("Matches").Cells(NumOfMatches, 9) = 
Workbooks(CurrentlyOpen & ".xlsb").Sheets(CurrentlyOpen).Cells(StartAt + j, 4) 
    Workbooks(DataWkbk).Sheets("Matches").Cells(NumOfMatches, 10) = 
Workbooks(CurrentlyOpen & ".xlsb").Sheets(CurrentlyOpen).Cells(StartAt + j, 5) 
    Workbooks(DataWkbk).Sheets("Matches").Cells(NumOfMatches, 11) = 
Workbooks(CurrentlyOpen & ".xlsb").Sheets(CurrentlyOpen).Cells(StartAt + j, 6) 
     
    Previous = i 
     
    End If 
End If 
j = j + 1 
Loop Until (Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 2).Value2 + 100 < 
Workbooks(CurrentlyOpen & ".xlsb").Sheets(CurrentlyOpen).Cells(StartAt + j, 
2).Value2) Or (StartAt + j = chrNumOfRows) 
'&&&&& MATCH FINDING &&&&& ends 
'We found all the possible matches for the current, i-th row. The difference between 
liver data we're supposed to match is larger than 100. There's also another check here. 
 
'Next row! 
i = i + 1 
 
If Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 2).Value2 - 100 > 
Workbooks(CurrentlyOpen & ".xlsb").Sheets(CurrentlyOpen).Cells(chrNumOfRows, 
2) Then 
Do Until CurrentlyOpen <> Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 
1).Value2 
Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 9).Value2 = "No Matches" 
Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 10).Value2 = "-" 







Progress = i / NumOfRows 
MakingProgress2.ProgressBar.Width = Round(Progress * 200) 
MakingProgress2.ProgressText.Caption = Format(Progress * 100, "0.00") & "%" 
MakingProgress2.Caption = i & "/" & NumOfRows 
MakingProgress2.InfoBox.Caption = NumOfMatches & " matches so far." & " 




Loop Until CurrentlyOpen <> Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 
1).Value2 
'***** 1ST NESTED LOOP ***** ends 
'The next row's chr# is different than the current one. We have to open a new file. 
'Close the old one first. 
Workbooks(CurrentlyOpen & ".xlsb").Close 
 
If i >= NumOfRows Then Exit Do 
Loop Until i = NumOfRows 
'##### MAIN LOOP ##### ends 
 




'The End                







Step 3.5 VBA: Annotate Individual Transcripts 
 
Sub step3andahalf() 
Dim chrNumOfRows, NumOfRows, StartAt, NumOfMatches As Long 
Dim Progress As Double 
Dim CurrentlyOpen, DataSheet, DataWkbk As String 
Dim WhichColor, Previous As Integer 
 
'COLOR SETUP 
'Set up some arrays for the colors. These are used later to "block" the matches that 
from the same data row. 
R = Array(255, 181, 154, 193, 134, 251) 
G = Array(250, 225, 206, 179, 207, 182) 
B = Array(129, 174, 223, 215, 190, 209) 
WhichColor = 0 
 
'COUNTS ROWS 
'NumOfRows: length of DataToMatch 




'Show the ProgressBar2 UserForm.  
MakingProgress2.Show vbModeless 
Progress = 0 
 
'OTHER PREPARATIONS 
'Sort data.  
Application.ScreenUpdating = False 
ThisWorkbook.ActiveSheet.Columns("A:H").Sort key1:=Range("a1"), _ 
        order1:=xlAscending, key2:=Range("b1"), order2:=xlAscending 
Application.ScreenUpdating = True 
 
'SAVE THE NAMES 
DataSheet = ActiveSheet.Name 
DataWkbk = ThisWorkbook.Name 
 
NumOfMatches = 0 
i = 1 
 
'CREATE NEW SHEET 
Workbooks(DataWkbk).Sheets.Add.Name = "Matches" 
 
'##### MAIN LOOP ##### starts 
 56 
 
'It runs until we get to the end of the file (meaning i = the number of rows it needs to 
go through). 
'You'll see this condition at the very end of the code in a row starting with "Loop 
Until". Watch the #####s! 
Do 
 
CurrentlyOpen = Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 1).Value2 
'MsgBox (i & "  Opening " & Workbooks(DataWkbk).Path & "\processed\" & 
CurrentlyOpen & ".xlsb") 
Application.ScreenUpdating = False 
 
'OPEN FILE 
If Dir(Workbooks(DataWkbk).Path & "\processed\" & CurrentlyOpen & ".xlsb") = "" 
Then 
    Workbooks.Open (Workbooks(DataWkbk).Path & "\processed\" & "chrM.xlsb") 
    CurrentlyOpen = "chrM" 
    Else: Workbooks.Open (Workbooks(DataWkbk).Path & "\processed\" & 
CurrentlyOpen & ".xlsb") 
End If 
Application.ScreenUpdating = True 
 
'Another file length count, but this time it's the chr# file. 




'***** 1ST NESTED LOOP ***** starts 
'A new file will only need to be opened if the next row's chr# is different from the 
current one. 
'Again, you can see this later when this loop ends in a row starting with "Loop Until". 




'@@@@@ FIND WHERE TO START LOOKING @@@@@ 
For j = 1 To 50 
 
'IF[              current liver data value                ] >= [                             chr# file, 2-4-
6%th row liver data value                                  ] 
If Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 2).Value2 >= 
Workbooks(CurrentlyOpen & ".xlsb").Sheets(CurrentlyOpen).Cells(1 + Round((j - 1) 
* chrNumOfRows / 50), 2) Then 
    If j = 50 Then StartAt = Round(chrNumOfRows * 0.98) - 200 




   'IF [              current liver data value                ] >= [                             chr# file, 4-6-
8%th row liver data value                              ] 
    If Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 2).Value2 <= 
Workbooks(CurrentlyOpen & ".xlsb").Sheets(CurrentlyOpen).Cells(1 + Round((j) * 
chrNumOfRows / 50), 2) Then 
         
        'We only get here if we found the interval our matches are in. 
        StartAt = Round(chrNumOfRows / 50 * (j - 1)) - 200 
         
        Exit For 




If StartAt < 1 Then StartAt = 1 
'@@@@@ FOUND WHERE TO START LOOKING @@@@@ 
 
'debugging only 
Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 9).Value2 = "No Matches" 
Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 10).Value2 = StartAt 
'Now we know where we should start looking. 
 
j = 0 
 
'&&&&& MATCH FINDING &&&&& starts 
 
Do 
If ((Abs(Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 2).Value2 - 
Workbooks(CurrentlyOpen & ".xlsb").Sheets(CurrentlyOpen).Cells(StartAt + j, 
2).Value2) <= 100) Or (Abs(Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 
3).Value2 - Workbooks(CurrentlyOpen & 
".xlsb").Sheets(CurrentlyOpen).Cells(StartAt + j, 3).Value2) <= 100)) Then 
    'Abs() gives you the absolute value of something. Basically what we're calculating 
here: 
    'If Abs(liver data - chr file liver data) is<= 100 then If Abs(testis data - chr file testis 
data) is <= 100 then we have a match! 
    'We start the search at the StartAt row, we use j to loop until the difference is 
greater than 100. If either of the Ifs fail, we jump straight to the next j. 
     
    'We have a match! 
    NumOfMatches = NumOfMatches + 1 
    Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 9).Value2 = "Match!" 'debug 
only, this is in the original data file 
     
    If (NumOfMatches > 1 And Previous <> i) Then 
 58 
 
        If Workbooks(DataWkbk).Sheets("Matches").Cells(NumOfMatches, 1).Value2 
<> Workbooks(DataWkbk).Sheets("Matches").Cells(NumOfMatches - 1, 1).Value2 
Then 
        WhichColor = WhichColor + 1 
        Workbooks(DataWkbk).Activate 
        If WhichColor = 5 Then WhichColor = 0 
    End If 
    End If 
     
     
    'Now we take the match and its associated data and put it in a new row in our 
Matches sheet. 
    Workbooks(DataWkbk).Sheets("Matches").Rows(NumOfMatches).Interior.Color = 
RGB(R(WhichColor), G(WhichColor), B(WhichColor)) 
     
    Workbooks(DataWkbk).Sheets("Matches").Cells(NumOfMatches, 1) = 
CurrentlyOpen 
    Workbooks(DataWkbk).Sheets("Matches").Cells(NumOfMatches, 2) = 
Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 2) 
    Workbooks(DataWkbk).Sheets("Matches").Cells(NumOfMatches, 3) = 
Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 3) 
    Workbooks(DataWkbk).Sheets("Matches").Cells(NumOfMatches, 4) = 
Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 4) 
    Workbooks(DataWkbk).Sheets("Matches").Cells(NumOfMatches, 5) = 
Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 5) 
    Workbooks(DataWkbk).Sheets("Matches").Cells(NumOfMatches, 6) = 
Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 6) 
    Workbooks(DataWkbk).Sheets("Matches").Cells(NumOfMatches, 7) = 
Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 7) 
    Workbooks(DataWkbk).Sheets("Matches").Cells(NumOfMatches, 8) = 
Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 8) 
    Workbooks(DataWkbk).Sheets("Matches").Cells(NumOfMatches, 9) = 
Workbooks(CurrentlyOpen & ".xlsb").Sheets(CurrentlyOpen).Cells(StartAt + j, 4) 
    Workbooks(DataWkbk).Sheets("Matches").Cells(NumOfMatches, 10) = 
Workbooks(CurrentlyOpen & ".xlsb").Sheets(CurrentlyOpen).Cells(StartAt + j, 5) 
    Workbooks(DataWkbk).Sheets("Matches").Cells(NumOfMatches, 11) = 
Workbooks(CurrentlyOpen & ".xlsb").Sheets(CurrentlyOpen).Cells(StartAt + j, 6) 
     
    Previous = i 
     
    If (Abs(Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 2).Value2 - 
Workbooks(CurrentlyOpen & ".xlsb").Sheets(CurrentlyOpen).Cells(StartAt + j, 
2).Value2) <= 100) Then 




    If (Abs(Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 3).Value2 - 
Workbooks(CurrentlyOpen & ".xlsb").Sheets(CurrentlyOpen).Cells(StartAt + j, 
3).Value2) <= 100) Then 
Workbooks(DataWkbk).Sheets("Matches").Cells(NumOfMatches, 3).Font.Bold = 
True 
 
        End If 
     
j = j + 1 
Loop Until ((Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 2).Value2 + 100 < 
Workbooks(CurrentlyOpen & ".xlsb").Sheets(CurrentlyOpen).Cells(StartAt + j, 
2).Value2) And (Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 3).Value2 + 100 
< Workbooks(CurrentlyOpen & ".xlsb").Sheets(CurrentlyOpen).Cells(StartAt + j, 
3).Value2)) Or (StartAt + j = chrNumOfRows) 
'&&&&& MATCH FINDING &&&&& ends 
 
'Next row! 
i = i + 1 
 
 
'This is here to speed things up. It tends to happen that the to-be-matched liver data 
goes all the way up to 2 million, while the related chr# file's liver data ends at 1 
million. 
'In that case it'll loop through the data until it finds the next chr# (from chr11 to chr12, 
for example). 
If Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 2).Value2 - 100 > 
Workbooks(CurrentlyOpen & ".xlsb").Sheets(CurrentlyOpen).Cells(chrNumOfRows, 
2) Then 
Do Until CurrentlyOpen <> Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 
1).Value2 
Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 9).Value2 = "No Matches" 
Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 10).Value2 = "-" 







Progress = i / NumOfRows 
MakingProgress2.ProgressBar.Width = Round(Progress * 200) 
MakingProgress2.ProgressText.Caption = Format(Progress * 100, "0.00") & "%" 
MakingProgress2.Caption = i & "/" & NumOfRows 
MakingProgress2.InfoBox.Caption = NumOfMatches & " matches so far." & " 






Loop Until CurrentlyOpen <> Workbooks(DataWkbk).Sheets(DataSheet).Cells(i, 
1).Value2 
'***** 1ST NESTED LOOP ***** ends 
'The next row's chr# is different than the current one. We have to open a new file. 
 
'Close the old file first. 
Workbooks(CurrentlyOpen & ".xlsb").Close 
 
'This is when we basically go all the way back to the beginning of the MAIN LOOP, 
open a new file, and start looking for the matches there. Unless, of course, 
'we're already out of data to match. In that case: 
 
If i >= NumOfRows Then Exit Do 
Loop Until i = NumOfRows 





'The End               







Figure 1. Spermatogenesis 
Spermatogonial stem cells undergo a series of mitotic and meiotic divisions to 
form differentiated and mature spermatozoa during spermatogenesis.  
“N” = chromatid quantity 
Figure 2. Eukaryotic messenger RNA 
Mature messenger RNA (mRNA) structurally consists of a 5’cap, an non-coding 
untranslated region (UTR) flanking both 3’ and 5’-ends, poly(A)-signal marking 
for cleavage at downstream polyA-site, and a string of adenine residues attached to 
the post-transcriptionally modified transcript following polyadenylation. 
FIGURES 




















start of transcription polyA-signal/site 
5’ cap 5’ UTR coding region 3’ UTR poly(A) tail 
62 
 
Figure 4. Alternative polyadenylation in the 3’UTR creates transcript 
isoforms 
The white bar represents an mRNA 3’UTR. Usage of variant PAS and cleavage 
at different polyA-sites involved with alternative polyadenylation results in 
truncation of the 3’UTR and transcript isoforms that may have altered 
downstream metabolism due to escape from regulatory sequence elements. 




Figure 3. Polyadenylation 
Polyadenylation in eukaryotic cells occurs before transcription is completed in the 
nascent mRNA. It involves the binding of Cleavage and Polyadenylation 
Specificity Factor (CPSF) to a polyadenylation signal (PAS) and recruitment of 
Poly(A) Polymerase. Downstream at a GU-rich region, Cleavage Stimulation 
Factor (CstF) is recruited by CPSF and cleaves the transcript at the polyA-site. 
PAP initiates the addition of adenine residues to make up the poly(A)-tail.  
5’ 3’ 









Figure 5. Bioinformatics analysis workflow  
Data processing and workflow for PolyA-seq analysis and transcript annotations. 
64 
 
Figure 6. Graphical representation of PAS use in mouse  
A) Depicts PAS use in all comprehensive transcripts in testis (dark gray 
bars) and liver (light gray bars) at the same polyA-site within a 100bp 
margin.  
B) Depicts PAS use in “honed” transcripts, where testis reads are greater 
than liver by at least one and PAS differ between matched transcripts at 





Figure 8. Two distinct cell populations were identified with DRAQ5 nuclear 
stain 
FACS histogram depicting two distinct populations based on fluorescence by 
DRAQ5 emission. spermatocyte and round spermatid populations are labeled 
Based on cell-specific PCR markers. 
P2 
Figure 7. Size distribution of male germ cells and gating for live cells 
Live cells were gated into populations based on size. The P1 population was 




Figure 9. PolyA-seq libraries from mouse 
PolyA-seq libraries from mouse testicular tissue, liver, and pooled male germ cells 
(round spermatids and spermatocytes). Male Germ Cells 1 and Male Germ Cells 2 
indicate prepared libraries from two separate sorts and biological replicates.  
67 
 
Table 1. Testis-specific genes with alternative poly(A) signals in the 3'-UTR  
 
Literature-mined testis-specific transcripts with APA-mediated 3’UTR isoforms as 




















4.5 4.5 Northern blot Thekkumkara et 
al., 1992 
Basic leucine 
zipper and W2 
domains 1 (BZW1) 
2.9 1.8 Northern blot, 
5'- and 3'RACE, 
Western blot 
Yu et al., 2006 
Cleavage 
polyadenylation 
specificity factor 6 
(CPSF6) 
4.0 2.1 Northern blot, 
3'RACE 







4.5 1.1 Northern blot, 
3'RACE 






2.4 1.8 Northern blot, 
3'RACE 




5 4.4, 3.2 Northern blot, 
RT-PCR 












Goodman et al., 
2005 
RanGAP1 3.5 3.5, 2.8 Northern blot Krebber & 
Ponstingl, 1996 
Ring finger protein 
4 (RNF4/SNURF) 
3.0 3.0, 1.6 Northern blot Yan et al., 2002 
Sp1 transcription 
factor (Sp1) 
8.8 4.1, 3.7, 
3.2, 1.4 
Northern blot Thomas et al., 
2005 
Translation 
initiation factor 2α 
(eIF-2α) 










Number of Transcripts 
Honed Percent of Transcripts Honed 
Human 1 1082 5.435% 
Human 2 546 5.363% 
Table 2. Human transcript numerical data 
Numerical data for PolyA-seq data following annotation and creation of “honed” 





Transcripts Percent of Transcripts Annotated 
Human 1 19906 143 0.718% 










AATAAA 9141 4140.817 9192.5 4232.034 0.991 
ACTAAA 143.5 67.175 138.5 60.104 0.944 
ATTAAA 2970.5 1354.109 2926.5 1318.754 0.976 
AGTAAA 679 298.399 659.5 283.549 0.952 
TATAAA 679.5 316.076 681.5 297.691 0.995 
GATAAA 276 128.693 262.5 127.986 0.925 
AATATA 298 144.249 311 135.764 0.934 
CATAAA 353.5 170.412 360.5 174.655 0.971 
AAAAAG 159 79.195 159.5 88.388 0.995 
AATACA 344 181.019 352 161.220 0.967 
Table 3. Human PAS statistics 
Counts for PAS usage in both human PolyA-seq data files for testis and liver were 
compared for differential usage. Standard deviation and P-values calculated using 






































































































































































































































































































































































































































































































































































































































































































































































































































Number of  
Transcripts  
Annotated 









Mouse 6341 34 0.536% 251 3.958% 







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 9. Literature-mined transcripts in PolyA-seq data 






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 11. Mouse honed transcript subset 
Mouse honed transcripts, where testis and liver transcripts are matched to the same 
polyA-site within a 100bp upstream and 100bp downstream, and extracted to retain 




Table 12. Individual testis and liver tissue transcript annotation numerical 
data from mouse 
PolyA-seq tissue files from mouse were individually annotated to identify 
potential transcript isoforms using different polyA-sites in alternative 
polyadenylation. 
 Testis Liver 
Transcripts with Isoforms 61 83 
Transcripts with 2 Isoforms 44 64 













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































cellular process 14 16.66666667 
cell communication (9), cell cycle 
(4), cellular component movement 
(2), cytokinesis (2) 
metabolic process 14 16.66666667 
biosyntheric process (2), catabolic 
process (1), generation of 
precursor metabolites and energy 
(1), nitrogen compound process 
(3), phosphate-containing 
compound metabolic process (2), 
primary metabolic process (10) 
localization 12 14.28571429 RNA localization (1), transport 
biological regulation 9 10.71428571 
regulation of biological processes 
(3), regulation of molecular 
function (7) 
developmental process 7 8.333333333 
anatomical structure 
morphogenesis (3), cell 
differentiation (1), death (1), 
ectoderm development (1), 
mesoderm development (4), 
response to stimulus 7 8.333333333 
cellular defense response (1), 
immune response (2), response to 
biotic stimulus (1), response to 
external stimulus (2), response to 
cellular component 
organization or 
biogenesis 6 7.142857143 
cellular component biogenesis (1), 
cellular component organization 
(6) 
immune system process 6 7.142857143 immune response (2) 
multicelluar organismal 
process 6 7.142857143 
single-multicellular organism 
process (1) 
apoptotic process 1 1.19047619 [no hit for lower level categories] 
biological adhesion 1 1.19047619 cell adhesion (1) 
reproduction 1 1.19047619 gamete generation (1) 
Table 15. Gene ontology for biological processes in mouse annotated 
transcripts 
Gene ontology (GO) was performed on comprehensive mouse annotated transcripts 












C-Kit kit kit oncogene spermatogonia 145 - - 
GFRα-1 
glial cell line 
derived neurotropic 
factor family 





polypeptide 1 Leydig 169 - - 
SYCP3 
synaptonemal 
complex protein 3 Spermatocyte 469 - + 
Dbil5 
diazepam binding 
inhibitor-like 5 round spermatid 121 + - 
PRM2 protamine 2 round spermatid 276 + - 
FSHR 
follicle stimulating 





Number bps Forward Primer 5' --> 3' Reverse Primer 5' --> 3' 



































Table 17. Germ cell-specific primers used in PCR validation 
Table 16. Isolated male germ cell purity validated with germ cell-specific 
primers 
“+” = gene amplification, indicated by banding on gels, following RT-PCR  
 “-” = no gene amplification  
104 
 
 Input Output Percent Yield 
Mouse Testis RNA 5µg 15.71ng 0.314% 
Male Germ Cell 
RNA 2.5-5µg 0.8-2ng 0.04% 
Table 18. Production of polyA+ mRNA 
Yield of polyA+ mRNA from total RNA of male germ cell populations using the Ol-
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